Section 43

EurekaMag PDF full texts Chapter 42,215


Bochenek, Z.; Fialkowska, D.; Kuś, J. 1973: Alloplastic materials in reconstruction of ossicle chain. Otolaryngologia Polska 27(4): 463-466
Pasquali, E. 1965: Alloplastic materials in repair of voluminous post-laparotomic hernias. Chirurgia Italiana 17(1): 134-146
Müller-Jensen, K. 1972: Alloplastic methods in ophthalmic surgery. Munchener Medizinische Wochenschrift 114(8): 333-341
Haussmann, P. 1983: Alloplastic partial replacement of the scaphoid bone. Handchirurgie Mikrochirurgie Plastische Chirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft für Handchirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der Peripheren Nerven und Gefasse: Organ der V. 15(3): 182-184
Borri, P.; Bianchi, V.; Seghezzi, R.; Bonandrini, L. 1971: Alloplastic prostheses in surgical treatment of lymphedema of the lower extremities. Minerva Chirurgica 26(1): 12-23
Atamaniuk, M.I.; Melrose, D.G. 1966: Alloplastic prosthesis for reconstructive operations on the trachea. Khirurgiia 42(1): 58-65
Spreter von Kreudenstein 1971: Alloplastic reconstruction of the chin in bird face by intraosseous anchorage of plastic implants. Zahnarztliche Praxis 22(4): 37-38
Mukhin, E.P. 1965: Alloplastic reconstruction of the inguinal canal as a method of herniotomy. Vestnik Khirurgii Imeni I. I. Grekova 95(10): 111-112
Mockwitz, J. 1985: Alloplastic reconstruction of the ligament of the knee in chronic rotation instabilities--technics and results. Unfallchirurgie 11(6): 289-294
Schulitz, K.P.; Plaue, R.; Städtler, J. 1974: Alloplastic replacement after segmental resection for tumor of the proximal end of femur. Zeitschrift für Orthopadie und ihre Grenzgebiete 112(5): 1086-1095
Mockwitz, J. 1985: Alloplastic replacement in chronic isolated rupture of the cruciate ligament--technic and results. Unfallchirurgie 11(6): 295-301
Koroleva, N.S. 1966: Alloplastic replacement of circular defects on the trachea in an experiment. Grudnaia Khirurgiia 8(2): 90-94
Metz, J.; Jüde, H.D.; Metz, G. 1973: Alloplastic replacement of the auricle following mutilating surgery. Zeitschrift für Haut- und Geschlechtskrankheiten 48(9): 329-335
Kelâmi, A.; Korb, G.; Ludtke-Handjery, A.; Rolle, J.; Schnell, J.; Lehnhardt, F.H. 1971: Alloplastic replacement of the partially resected urethra on dogs. Investigative Urology 9(1): 55-58
Hansen, O.H.; Rasmussen, F.; Hansen, J.P. 1974: Alloplastic replacement of the partially resected urinary bladder in dogs. Scandinavian Journal of Urology and Nephrology 8(1): 7-9
Kelâmi, A.; Lüdtke-Handjery, A.; Korb, G.; Rolle, J.; Schnell, J.; Danigel, K.H. 1970: Alloplastic replacement of the urinary bladder wall with lyophilized human dura. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 2(3): 195-202
Wagenknecht, L.V. 1994: Alloplastic spermatocele: 20 years experience and perspectives. Acta Chirurgica Hungarica 34(3-4): 207-229
Weiss, M.; Kiwerski, J. 1980: Alloplastic springs in the treatment of spinal fractures associated with spinal cord injuries. Beitrage Zur Orthopadie und Traumatologie 27(5): 246-252
Spranger, M. 1972: Alloplastic substitution of joint cartilage. First communication. Zeitschrift für Orthopadie und ihre Grenzgebiete 110(3): 400-402
Picciocchi, A.; Granone, P.; Panebianco, V.; Budini, M.; Montalto, G.; Lemmo, G.; Cascone, C.; D'Ugo, D.; Terribile, D. 1982: Alloplastic tracheal prostheses: experimental contribution. Chirurgia E Patologia Sperimentale 29(3): 121-130
Hofmann, D.; Filler, D.; Fritz, K.W.; Jander, R. 1980: Alloplastic tracheal prosthesis with biocarbone. a study of animal experiments. Langenbecks Archiv für Chirurgie 350(3): 199-206
Müller-Jensen, K. 1974: Alloplastic vitreous replacement with acrylamide. A preliminary report. Modern problems in ophthalmology 12(0): 385-389
Bulaenko, I.P. 1966: Alloplastics of extensive defects of the chest wall and ribs under experimental conditions. Eksperimental'naia Khirurgiia i Anesteziologiia 11(3): 15-17
Pastukhova, L.I. 1974: Alloplasty after resection of the solitary kidney under experimental conditions. Eksperimental'naia Khirurgiia i Anesteziologiia 1974(3): 40-41
Bluvshteĭn, G.M. 1969: Alloplasty in absence of the incus. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 29(1): 78-82
Rybkina, L.V. 1972: Alloplasty in an edematous type of corneal dystrophy. Vestnik Oftalmologii 1: 6-9
Bulynin, I.I. 1965: Alloplasty in external abdominal hernia. Klinicheskaia Khirurgiia 5: 31-34
Spitserev, A.Kh. 1969: Alloplasty in herniotomy of cattle. Veterinariia 46(2): 68-70
Maslova, K.D. 1973: Alloplasty in herniotomy on swine. Veterinariia 10: 102-104
Liandres, Z.A. 1969: Alloplasty in paralytic hip dislocation in children. Ortopediia Travmatologiia i Protezirovanie 30(10): 72-74
Shuster, M.A.; Bulanov, V.V. 1967: Alloplasty in surgery of stable paralysis of the facial nerve. Stomatologiia 46(3): 40-43
Chesnokova, G.D.; Dovgan', E.G.; Veller, O.R.; Kotova, L.S. 1966: Alloplasty in surgery. (Review of the foreign literature of 1963-1964). Khirurgiia 42(10): 125-130
Vaĭnberg, Z.S.; Simovskiĭ-Veĭtkov, R.S. 1965: Alloplasty in the surgical treatment of impotence. Urologiia i Nefrologiia 30(5): 42-45
Pap, K.; Gaál, J. 1965: Alloplasty in the treatment of bone tumors. Beitrage Zur Orthopadie und Traumatologie 12(10): 686-687
Movshovich, I.A. 1971: Alloplasty in traumatology and orthopedics. Ortopediia Travmatologiia i Protezirovanie 32(3): 73-80
Kelâmi, A. 1972: Alloplasty in urology. Zeitschrift für Urologie und Nephrologie 65(3): 161-173
Chekharina, E.A. 1966: Alloplasty of a defect of the anterior peritoneal wall after excision of a large size desmoid tumor. Voprosy Onkologii 12(4): 102-103
Lytkin, M.I.; Lebedev, L.V.; Kurygin, A.A. 1965: Alloplasty of arteries in injuries of the magistral vessels and their sequelae. Ortopediia Travmatologiia i Protezirovanie 26(8): 23-28
Anisimov, V.N. 1973: Alloplasty of carpal bones. Vestnik Khirurgii Imeni I. I. Grekova 110(1): 116-118
Kargapol'tseva, G.V. 1980: Alloplasty of cranial defects in children. Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 2: 22-26
Kotsiubinskiĭ, I.G. 1969: Alloplasty of defects of the abdominal and thoracic walls with plastic materials following removal of tumors. Khirurgiia 45(9): 41-46
Meskhiia, N.S. 1971: Alloplasty of dural defects and its surgical consequences. Voprosy Neirokhirurgii 35(6): 50-53
Tserentsian, D.M. 1967: Alloplasty of postoperative and recurrent hernias. Sovetskaia Meditsina 30(8): 89-91
Ivanchenko, I.A. 1966: Alloplasty of the abdominal aorta using capron cloth in large lateral defects. Eksperimental'naia Khirurgiia i Anesteziologiia 11(4): 17-18
Mays, E.T.; Weakley, S. 1971: Alloplasty of the abdominal wall after extensive cancer surgery. American Journal of Surgery 122(6): 781-784
Amirow, F.F. 1967: Alloplasty of the adbominal aorta in experiments. Zentralblatt für Chirurgie 92(26a Pt 2: 1560-1562
Chukhrienko, D.P.; Kovalenko, L.N.; Titarenko, A.A. 1966: Alloplasty of the anterior abdominal wall in hernias. Vestnik Khirurgii Imeni I. I. Grekova 97(7): 56-59
Ol'shanskii, I.O.; Rakhman, Z.I. 1972: Alloplasty of the cardiac wall following excision of an infarcted zone. Eksperimental'naia Khirurgiia i Anesteziologiia 17(5): 25-28
Nazarenko, I.G. 1967: Alloplasty of the chest wall after extensive resection of ribs for tumor surgery. Klinicheskaia Khirurgiia 7: 60-62
Puchkovskaia, N.A.; Muchnik, S.R.; Golubenko, E.A. 1970: Alloplasty of the cornea. Oftalmologicheskii Zhurnal 25(4): 247-252
Sinevich, E.E. 1966: Alloplasty of the diaphragm. Eksperimental'naia Khirurgiia i Anesteziologiia 11(5): 37
Kaplan, A.V.; Lirtsman, V.M. 1970: Alloplasty of the femoral head in aged persons. Ortopediia Travmatologiia i Protezirovanie 31(10): 12-17
Volkov, M.V.; Sivach, K.M. 1966: Alloplasty of the hip in the USSR. Acta Orthopaedica Belgica 32(2): 313-326
Sivash, K.M. 1974: Alloplasty of the hip joint. Khirurgiia 12: 13-17
Breitenfelder, J.; Spranger, M. 1973: Alloplasty of the hip joint in animal experiments. Archiv für Orthopadische und Unfall-Chirurgie 76(2): 89-95
Kanková, D.; Dostál, C.; Gatterová, J.; Trnavský, K.; Rybka, V.; Vavrík, P. 1984: Alloplasty of the knee joint in progressive polyarthritis and osteoarthritis. Bratislavske Lekarske Listy 82(5): 1356-1361
Kurilin, I.A.; Tyshko, F.A. 1966: Alloplasty of the larynx and trachea using capron mesh. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 26(5): 52-58
Samoĭlov, G.S. 1965: Alloplasty of the patella. Ortopediia Travmatologiia i Protezirovanie 26(8): 20-23
Pokrovskii, A.V.; Apsatarov, E.A.; Klioner, L.I.; Kulkova, I.A. 1973: Alloplasty of the segment of vena cava inferior in the conditions of functioning arterio-venous fistula. Klinicheskaia Khirurgiia 7: 25-28
Donev, M.; Dakov, I.; Donev, S.v. 1973: Alloplasty of the thoracic wall using lyophilized dura mater with case report. Khirurgiia 26(1): 13-17
Atamaniuk, M.I.; Tkachenko, E.G. 1973: Alloplasty of tracheal bifurcation under experimental conditions. Eksperimental'naia Khirurgiia i Anesteziologiia 18(5): 20-21
Pavlanský, R.; Cefelín, P.; Stehlícek, J. 1968: Alloplasty with artificial substances in a malignant neoplasm of the proximal end of the femur. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 35(3): 216-219
Pawelec, G.; Wernet, P.; Rehbein, A.; Balko, I.; Schneider, E.M. 1984: Alloproliferative human T cell clones primed and cultured in vitro lose proliferative and gain suppressive activity with age. Human Immunology 10(2): 135-142
Shalimov, A.A.; Driuk, N.F.; Tupikin, V.G.; Kalita, N.I. 1984: Alloprosthesis of the renal veins and inferior vena cava after resecting them from patients with neoplasms of the retroperitoneal space. Klinicheskaia Khirurgiia 5: 34-36
Watts, R.W.; Watkins, P.J.; Matthias, J.Q.; Gibbs, D.A. 1966: Allopurinal and acute uric acid nephropathy. British Medical Journal 1(5481): 205-208
Rapado Errazti, A. 1965: Allopurinol (HPP) in the treatment of gout and hyperuricemia due to thiazide diuretics. Revista Clinica Espanola 98(2): 133-137
Rapado Errazti, A. 1965: Allopurinol (HPP) in the treatment of gout and in thiazide-induced hyperuricemia. Bulletin of the Institute for Medical Research University of Madrid 18(4): 167-176
Wexler, B.C.; McMurtry, J.P. 1981: Allopurinol amelioration of the pathophysiology of acute myocardial infarction in rats. Atherosclerosis 39(1): 71-87
Smith, M.J. 1973: Allopurinol and calcium-stone formers. Lancet 1(7798): 315
Lopez, H.H.; Goldman, S.M.; Liberman, I.I.; Barnes, D.T. 1974: Cannabis--accidental peroral intoxication. the hashish smuggler roentogenographically unmasked. JAMA 227(9): 1041-1042
Williams, E.B.; Owen, R.T. 1980: Allopurinol and diuretic-induced hyperuricaemia. Lancet 2(8208-8209): 1381
Ahmad, S. 1995: Allopurinol and enalapril. Drug induced anaphylactic coronary spasm and acute myocardial infarction. Chest 108(2): 586
Foster, D.M.; Lee, C.S.; O'Sullivan, W.J. 1973: Allopurinol and enzymes of de novo pyrimidine biosynthesis. Biochemical Medicine 7(1): 61-67
Giordano, G.; Marugo, M.; Caraceni, C.E.; Minuto, F. 1968: Allopurinol and hyperuricemia caused by fructose. Archivio "e. Maragliano" di Patologia E Clinica 24(4): 395-406
Owens, M.L.; Lazarus, H.M.; Wolcott, M.W.; Maxwell, J.G.; Taylor, J.B. 1974: Allopurinol and hypoxanthine pretreatment of canine kidney donors. Transplantation 17(4): 424-427
Laval, J. 1968: Allopurinol and macular lesions. Archives of Ophthalmology 80(3): 415
Kelley, W.N.; Fox, I.H.; Beardmore, T.D.; Meade, J.C. 1971: Allopurinol and oxipurinol: alteration of purine and pyrimidine metabolism in cell culture. Annals of the new York Academy of Sciences 179: 588-595
Anonymous 1968: Allopurinol and purine production. Lancet 1(7554): 1239-1240
Anonymous 1968: Allopurinol and the control of hyperuricemia in neoplastic disease. Medical Letter on Drugs and Therapeutics 10(25): 103-104
Wood, M.H.; Sebel, E.; O'Sullivan, W.J. 1972: Allopurinol and thiazides. Lancet 1(7753): 751
Auscher, C.; Mercier, N.; Pasquier, C.; Delbarre, F. 1974: Allopurinol and thiopurinol: effect in vivo on urinary oxypurine excretion and rate of synthesis of their ribonucleotides in different enzymatic deficiencies. Advances in Experimental Medicine and Biology 41: 657-662
Smith, M.J.; Boyce, W.H. 1969: Allopurinol and urolithiasis. Journal of Urology 102(6): 750-753
Wyngaarden, J.B. 1970: Allopurinol and xanthine nephropathy. New England Journal of Medicine 283(7): 371-372
Anderson, E.E.; Rundles, R.W.; Silberman, H.R.; Metz, E.N. 1967: Allopurinol control of hyperuricosuria: a new concept in the prevention of uric acid stones. Journal of Urology 97(2): 344-347
Wasko, R.; Frankenfield, B.A. 1968: Allopurinol dissolution of renal uric acid calculi. JAMA 205(11): 801
Kirwan, J.R. 1982: Allopurinol effect on renal function in gout. Annals of the Rheumatic Diseases 41(4): 435-436
Halbert, A.R.; Weston, W.L.; Morelli, J.G. 1995: Allopurinol for Old World cutaneous leishmaniasis. Pediatric Dermatology 12(3): 287-288
Anonymous 1966: Allopurinol for gout. Drug and Therapeutics Bulletin 4(11): 41-42
Griffiths, J.R.; Shuttlewood, R.J. 1980: Allopurinol for muscular dystrophy. Lancet 2(8191): 423-424
Shah, K.A.; Levin, J.; Rosen, N.; Greenwald, E.; Zumoff, B. 1982: Allopurinol hepatotoxicity potentiated by tamoxifen. New York State Journal of Medicine 82(12): 1745-1746
Al-Kawas, F.H.; Seeff, L.B.; Berendson, R.A.; Zimmerman, H.J.; Ishak, K.G. 1981: Allopurinol hepatotoxicity. Report of two cases and review of the literature. Annals of Internal Medicine 95(5): 588-590
Elasy, T.; Kaminsky, D.; Tracy, M.; Mehler, P.S. 1995: Allopurinol hypersensitivity syndrome revisited. Western Journal of Medicine 162(4): 360-361
Urban, T.; Maquarre, E.; Housset, C.; Chouaid, C.; Devin, E.; Lebeau, B. 1995: Allopurinol hypersensitivity. a possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment. Revue des Maladies Respiratoires 12(3): 314-316
Vinciullo, C. 1984: Allopurinol hypersensitivity: a potentially life threatening reaction. Australasian Journal of Dermatology 25(2): 59-67
Gardner-Medwin, D. 1980: Allopurinol in Duchenne dystrophy. Lancet 2(8185): 92
Gertner, J.J. 1973: Allopurinol in calcium-stone formation. Lancet 1(7807): 834
Rundles, R.W. 1966: Allopurinol in gouty nephropathy and renal dialysis. Annals of the Rheumatic Diseases 25(6 Suppl): 694-696
Clausen, J.E. 1967: Allopurinol in hyperuricemia. Ugeskrift for Laeger 129(30): 971-974
Levin, N.W.; Abrahams, O.L. 1966: Allopurinol in patients with impaired renal function. Annals of the Rheumatic Diseases 25(6 Suppl): 681-687
Kersley, G.D. 1966: Allopurinol in primary gout with and after the administration of uricosuric agents. Annals of the Rheumatic Diseases 25(6 Suppl): 643-644
Castro-Gago, M.; Jiménez, J.F.; Torres-Colomer, M.; Fuster, M.; Paz, M.; Novo, I.; Peña, J. 1980: Allopurinol in progressive muscular dystrophy. Anales Espanoles de Pediatria 13(10): 865-876
Viglioglia, P.A.; Plante, G.E.; Viglioglia, J.; Saraceno, E.F. 1970: Allopurinol in psoriasis. Dermatologica 141(3): 203-207
Feuerman, E.J.; Nir, M.A. 1973: Allopurinol in psoriasis--a double-blind study. British Journal of Dermatology 89(1): 83-86
Newton, D.R. 1966: Allopurinol in the management of gout. Annals of Physical Medicine 8(7): 235-241
Aldo, C.; Roberto, M. 1969: Allopurinol in the prevention and treatment of urate complications in leukemia. Haematologica 54(1): 17-28
Krakoff, I.H.; Balis, M.E. 1966: Allopurinol in the prevention of hyperuricaemia secondary to the treatment of neoplastic diseases with alkylating agents, adrenal steroids, and radiation therapy. Annals of the Rheumatic Diseases 25(6 Suppl): 651-654
De Vries, A.; Frank, M.; Liberman, U.A.; Sperling, O. 1966: Allopurinol in the prophylaxis of uric acid stones. Annals of the Rheumatic Diseases 25(6 Suppl): 691-693
Brambilla, I.; Cantoni, L. 1970: Allopurinol in the therapy of gout and secondary hyperuricemias. La Clinica Terapeutica 55(1): 45-61
Caudarella, R.; Stefani, F.; Malavolta, N.; Rizzoli, E.; Maccaferri, M.; D'Antuono, G. 1983: Allopurinol in the therapy of idiopathic calcic lithiasis. Giornale di Clinica Medica 64(5-6): 198-208
Watts, R.W. 1966: Allopurinol in the therapy of neoplasia and blood diseases. Metabolic aspects. Annals of the Rheumatic Diseases 25(6 Suppl): 657-659
Muszkowska-Penson, J.; Chodorowski, Z. 1969: Allopurinol in the treatment of gout. Polski Tygodnik Lekarski 24(8): 286-288
Lignière, G.C.; Cirla, E. 1968: Allopurinol in the treatment of gout. Preliminary report. Reumatismo 20(2): 101-103
Serre, H.; Simon, L.; Claustre, J. 1968: Allopurinol in the treatment of gout: initial results. Revue du Rhumatisme et des Maladies Osteo-Articulaires 35(6): 334-344
Wojtczak, A.; Krzymański, M. 1969: Allopurinol in the treatment of gouty nephropathy with renal insufficiency. Polski Tygodnik Lekarski 24(45): 1736-1737
Benedetti, A.; Nardini, A.; Busonera, G. 1968: Allopurinol in the treatment of hyperuricemia and chronic gout. La Clinica Terapeutica 45(2): 141-154
Healey, L.A. 1966: Allopurinol in the treatment of hyperuricemia and gout. Northwest Medicine 65(5): 400-403
Zilli, E. 1965: Semeiology of the parathyroid glands. Il Policlinico. Sezione Pratica 72(36): 1222-1225
Rapado, A. 1966: Allopurinol in thiazide-induced hyperuricaemia. Annals of the Rheumatic Diseases 25(6 Suppl): 660-666
Lowrey, J.C. 1972: Allopurinol in treatment of chronic "cystitis" in a Dalmatian dog. Veterinary Medicine Small Animal Clinician: Vm Sac 67(2): 165-172 Passim
Scott, J.T.; Hall, A.P.; Grahame, R. 1966: Allopurinol in treatment of gout. British Medical Journal 2(5509): 321-327
Bowie, E.A.; Simmonds, H.A.; North, J.D. 1967: Allopurinol in treatment of patients with gout and chronic renal failure. New Zealand Medical Journal 66(421): 606-611
Schwille, P.O.; Jügelt, U.; Sigel, A. 1972: Allopurinol induced electrolyte and metabolism changes in the urine of patients with kidney stones. Der Urologe. Ausg. a 11(4): 185-189
Bretag, A.H.; Stern, L.M.; Ballard, F.J.; Tomas, F.M.; Cooper, D.M.; Fewings, J.D.; Goldblatt, E. 1981: Allopurinol ineffective in Duchenne muscular dystrophy. Lancet 1(8214): 276
Rosenkrantz, H.; Schaeppi, U.; Fabry, A.; Davis, R.D.; Cooney, D.A. 1968: Allopurinol influence on iodine metabolism. Biochemical Pharmacology 17(11): 2357-2360
Appelbaum, S.J.; Mayersohn, M.; Dorr, R.T.; Perrier, D. 1982: Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration. Cancer ChemoTherapy and Pharmacology 8(1): 93-98
Yamanaka, H.; Nishioka, K.; Suzuki, T.; Kohno, K. 1983: Allopurinol metabolism in a patient with xanthine oxidase deficiency. Annals of the Rheumatic Diseases 42(6): 684-686
Fox, R.M.; Woods, R.L.; Tattersall, M.H.; Piper, A.A.; Sampson, D. 1981: Allopurinol modulation of fluorouracil toxicity. Cancer ChemoTherapy and Pharmacology 5(3): 151-155
Matzkóné Hollenbach, K.; Tráser, F.; Mezey, G. 1984: Allopurinol preparations for intravenous injection. Acta Pharmaceutica Hungarica 54(4): 187-192
Lazarus, H.M.; Owens, M.L.; Hopfenbeck, A. 1974: Allopurinol protection of hepatic nuclear function during hemorrhagic shock. Surgical Forum 25(0): 10-12
Rijhwani, A.; Sen, S.; Gunasekaran, S.; Ponnaiya, J.; Balasubramanian, K.A.; Mammen, K.E. 1995: Allopurinol reduces the severity of peritoneal adhesions in mice. Journal of Pediatric Surgery 30(4): 533-537
Billings, A.A.; Kandel, G.L.; Shapiro, C.M. 1969: Allopurinol therapy for renal uric acid calculi. JAMA 210(11): 2093-2094
Sjöberg, K.H. 1966: Allopurinol therapy of gout with renal complications. Annals of the Rheumatic Diseases 25(6 Suppl): 688-690
Earll, J.M.; Saavedra, M. 1984: Allopurinol toxicity and frequent relationship to reduced renal function. American Journal of Medicine 77(5): A81 A89
Suzuki, Y.; Sudo, J.; Tanabe, T. 1984: Allopurinol toxicity: its toxic organ-specificity between the liver and the kidney in the rat. Journal of Toxicological Sciences 9(4): 343-351
Delbarre, F.; Lagrue, G.; Frugier, J.C.; Aignan, M. 1967: Allopurinol treatment of gout with renal insufficiency. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 43(10): 644-651
Chodorowski, Z.; Muszkowska-Penson, J.; Stolarczyk, J. 1974: Allopurinol treatment of gout with special reference to patients with gouty nephropathy. Wiadomosci Lekarskie 27(8): 705-710
Nissen, N.I.; Paikin, H. 1967: Allopurinol treatment of hyperuricemia. Nordisk Medicin 78(41): 1320-1324
De Vries, A.; Frank, M.; Sperling, O. 1968: Allopurinol treatment of malignant uric acid lithiasis in a gouty patient with massive hyperuricosuria. Journal d'Urologie et de Nephrologie 74(4): 403-408
Frang, D.; Berényi, M.; Végh, A. 1973: Allopurinol treatment of patients with uric acid calculi. Acta Chirurgica Academiae Scientiarum Hungaricae 14(2): 105-111
Coe, F.L.; Raisen, L. 1973: Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet 1(7795): 129-131
Clausen, J.E. 1967: Allopurinol, a new drug in the therapy of arthritis urica. Ugeskrift for Laeger 129(30): 968-971
Anonymous 1971: Allopurinol, purines, and pyrimidines. Lancet 1(7689): 73
Lee, E.J.; Kueh, Y.K. 1982: Allopurinol--induced skin reactions and agranulocytosis. Singapore Medical Journal 23(3): 178-180
Chau, N.Y.; Reade, P.C.; Rich, A.M.; Hay, K.D. 1984: Allopurinol-amplified lichenoid reactions of the oral mucosa. Oral Surgery Oral Medicine and Oral Pathology 58(4): 397-400
Elion, G.B.; Williams, T.E. 1982: Allopurinol-induced suppressor T cell dysfunction. Journal of the American Academy of Dermatology 7(5): 687-688
Berken, A. 1981: Allopurinol-induced suppressor T cell dysfunction: a hypothesis. Journal of the American Academy of Dermatology 5(5): 607-608
Dan, M.; Jedwab, M.; Peled, M.; Shibolet, S. 1984: Allopurinol-induced toxic epidermal necrolysis. International Journal of Dermatology 23(2): 142-144
Ambanelli, U.; Ferraccioli, G.F. 1982: Allopurinol-like action of diflunisal. Arthritis and Rheumatism 25(4): 474-475
Weissman, A.M.; Christian, D.G.; Cornelis, W.A.; Fortner, C.L. 1973: Allopurinol-mercaptopurine interaction. Journal of the American Pharmaceutical Association 13(1): 2
Frayha, R.A. 1971: Allopurinol. a review. Le Journal Medical Libanais. Lebanese Medical Journal 24(5): 463-471
Kelley, W.N.; Beardmore, T.D. 1970: Allopurinol: alteration in pyrimidine metabolism in man. Science 169(3943): 388-390
Zucchelli, P.; Sasdelli, M.; Fusaroli, M. 1968: Allopurinol: its clinical use. Giornale di Clinica Medica 49(10): 1014-1037
Delgado, J.N.; Cosgrove, F.P.; Isaacson, E.I. 1966: Allopurinol: xanthine oxidase inhibitor. Texas Medicine 62(1): 100-101
Fitch, F.W. 1984: Alloreactive T cell clones. Advances in Experimental Medicine and Biology 172: 347-363
Suciu-Foca, N.; Rohowsky, C.; Coburn, C.; Reed, E.; Khan, R.; Lewison, A. 1981: Alloreactive T cells: expression of HLA-D antigens, stimulation of autologous MLR, and possible immunoregulatory function. Human Immunology 3(4): 301-312
Rao, A.; Allard, W.J.; Hogan, P.G.; Rosenson, R.S.; Cantor, H. 1983: Alloreactive T-cell clones. Ly phenotypes predict both function and specificity for major histocompatibility complex products. Immunogenetics 17(2): 147-165
Hardt, C.; Pfizenmaier, K.; Röllinghoff, M.; Klein, J.; Wagner, H. 1980: Alloreactive and H-2-restricted Lyt 23 cytotoxic T lymphocytes derive from a common pool of antecedent Lyt 123 precursors. Journal of Experimental Medicine 152(5): 1413-1418
Glasebrook, A.L.; Fitch, F.W. 1980: Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. Journal of Experimental Medicine 151(4): 876-895
Lutz, C.T.; Glasebrook, A.L.; Fitch, F.W. 1981: Alloreactive cloned T cell lines. III. Accessory cell requirements for the growth of cloned cytolytic T lymphocytes. Journal of Immunology 126(4): 1404-1408
Lutz, C.T.; Glasebrook, A.L.; Fitch, F.W. 1981: Alloreactive cloned T cell lines. IV. Interaction of alloantigen and T cell growth factors (TCGF) to stimulate cloned cytolytic T lymphocytes. Journal of Immunology 127(1): 391-392
Ely, J.M.; Prystowsky, M.B.; Eisenberg, L.; Quintans, J.; Goldwasser, E.; Glasebrook, A.L.; Fitch, F.W. 1981: Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant. Journal of Immunology 127(6): 2345-2349
Ely, J.M.; Fitch, F.W. 1983: Alloreactive cloned T cell lines. VII. Comparison of the kinetics of IL 2 release stimulated by alloantigen or Con a. Journal of Immunology 131(3): 1274-1279
Maryanski, J.L.; MacDonald, H.R.; Lees, R.K.; Sordat, B.; Cerottini, J.C. 1984: Alloreactive cytolytic T lymphocyte precursor cells in aged C57Bl/6 nu/nu mice: frequency and cell surface phenotype. Experimental Cell Biology 52(1-2): 21-24
Czitrom, A.A.; Katz, D.R.; Sunshine, G.H. 1982: Alloreactive cytotoxic T lymphocyte responses to H-2 products on purified accessory cells. Immunology 45(3): 553-560
Capková, J.; Hasek, M.; Kousalová, M.; Holán, V.; Boubelík, M. 1983: Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice. Folia Biologica 29(2): 200-208
Vánky, F.; Klein, E. 1982: Alloreactive cytotoxicity of interferon-triggered human lymphocytes detected with tumor biopsy targets. Immunogenetics 15(1): 31-39
Penninger, J.M.; Timms, E.; Shahinian, A.; Jezo-Bremond, A.; Nishina, H.; Ionescu, J.; Hedrick, S.M.; Mak, T.W. 1995: Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells. Journal of Immunology 155(8): 3847-3855
Sensi, M.L.; Parenza, M.; Parmiani, G. 1983: Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells. Journal of the National Cancer Institute 70(2): 291-297
Hanto, D.W.; Ruger, J.K.; Rossi, S.J. 1995: Alloresponses in vitro and in vivo show restricted T-cell receptor V beta gene usage. Transplantation Proceedings 27(1): 491-493
Sugimoto, M.; Chiba, J.; Egashira, Y. 1981: Allorestriction and xenorestriction phenomena in the induction of delayed-type hypersensitivity (DTH) responses in the guinea pig against azobenzenearsonate- (ABA) modified peritoneal exudate cells. Journal of Immunology 127(1): 306-311
Bear, R.H.; Roholt, O.A.; Pressman, D. 1980: Allosensitization protects against lethal challenge with a syngeneic mouse lymphoma. Transplantation Proceedings 12(1): 150-151
Carosella, E.; Bensussan, A.; Dausset, J.; Sasportes, M. 1981: Allosensitized T cells produce soluble factors susceptible to suppress allogeneic proliferation but not to interfere on cell mediated cytotoxicity. Medicina 41 Suppl: 65-76
Mitchison, N.A. 1981: Allospecific T cells. Cellular Immunology 62(2): 258-263
Yeh Ming; Czitrom, A.A.; Mitchison, N.A. 1982: Allospecific T-cell lines with functional activities. Immunology 46(2): 281-287
Reiss, C.S.; Evans, G.A.; Margulies, D.H.; Seidman, J.G.; Burakoff, S.J. 1983: Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proceedings of the National Academy of Sciences of the United States of America 80(9): 2709-2712
Friedman, S.M.; Thompson, G.S.; Principato, M.A. 1982: Allospecific human T cell lines and clones which mediate HLA-DR restricted helper activity. Journal of Immunology 129(6): 2451-2457
Engel, E.E.; Guttmann, R.D.; Fuks, A. 1982: Allospecific monoclonal antibodies recognizing rat class i and class Ii histocompatibility antigens. Transplantation 33(6): 631-635
Holán, V.; Mitchison, N.A. 1984: Allospecific suppression without requirement for participation of Ly 2+ cells. Immunology 51(3): 469-475
Dakhno, F.V.; Dibirov, M.K. 1981: Allospermoimmunization and fertility. Akusherstvo i Ginekologiia 6: 14-16
Takeo, K.; Murai, T.; Nagai, J.; Katsuki, H. 1967: Allosteric activation of DPN-linked malic enzyme from Escherichia coli by aspartate. Biochemical and Biophysical Research Communications 29(5): 717-722
Bachelard, H.S. 1971: Allosteric activation of brain hexokinase by magnesium ions and by magnesium ion--adenosine triphosphate complex. Biochemical Journal 125(1): 249-254
Erlanger, B.F.; Wassermann, N.H.; Cooper, A.G. 1973: Allosteric activation of chymotrypsin-catalyzed hydrolysis of specific substrates. Biochemical and Biophysical Research Communications 52(1): 208-215
Garreau, H.; Buc-Temkine, H. 1972: Allosteric activation of human erythrocyte pyruvate kinase by fructose-1,6-diphosphate. Kinetic and equilibrium binding studies. Biochimie 54(9): 1103-1107
Kuczenski, R.T.; Mandell, A.J. 1972: Allosteric activation of hypothalamic tyrosine hydroxylase by ions and sulphated mucopolysaccharides. Journal of Neurochemistry 19(1): 131-137
Yamazaki, M. 1970: Allosteric activation of nucleoside diphosphatase by ATP. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 15(13): 1354-1361
Keech, B.; Barritt, G.J. 1967: Allosteric activation of sheep kidney pyruvate carboxylase by the magnesium ion (Mg2+) and the magnesium adenosine triphosphate ion (MgATP2-). Journal of Biological Chemistry 242(9): 1983-1987
Esmann, V.; Sølling, H.; Juhl, H. 1981: Allosteric and covalent control of glycogen synthase from leukocytes. International Journal of Biochemistry 13(11): 1123-1126
Cassman, M. 1973: Allosteric and isosteric modifiers of NADH binding to cytoplasmic malic dehydrogenase. Biochemical and Biophysical Research Communications 53(2): 666-672
Formby, B.; Clausen, J. 1969: Allosteric and kinetic properties of a K-dependent acylphosphatase in rat brain synaptosomes and its possible relation to (Na+K) ATPase. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 350(8): 973-980
Cassman, M.; Vetterlein, D. 1974: Allosteric and nonallosteric interactions with reduced nicotinamide adenine dinucleotide in two forms of cytoplasmic malic dehydrogenase. Biochemistry 13(4): 684-689
Rowe, A.J.; Weitzman, P.D. 1969: Allosteric changes in citrate synthase observed by electron microscopy. Journal of Molecular Biology 43(2): 345-349
Goldemberg, A.L.; Farías, R.N.; Trucco, R.E. 1972: Allosteric changes of p-nitrophenylphosphatase from rat erythrocytes in fat deficiency. Journal of Biological Chemistry 247(13): 4299-4304
Swart, G.W.; Kraal, B.; Bosch, L.; Parmeggiani, A. 1982: Allosteric changes of the guanine nucleotide site of elongation factor EF-Tu: a comparative study of two kirromycin-resistant EF-Tu species. Febs Letters 142(1): 101-106
Kuo, L.C. 1983: Allosteric cofactor-mediated enzyme cooperativity: a theoretical treatment. Proceedings of the National Academy of Sciences of the United States of America 80(17): 5243-5247
Katsuki, H. 1967: Allosteric control of TCA cycle. Seikagaku. Journal of Japanese Biochemical Society 39(7): 377-389
London, J.; Meyer, E.; Kulczyk, S. 1970: Allosteric control of a Lactobacillus malate dehydrogenase (decarboxylating) by two glycolytic intermediate products. Biochimica et Biophysica Acta 212(3): 512-514
Niederman, R.A.; Rabinowitz, K.W.; Wood, W.A. 1969: Allosteric control of biodegradative L-threonine dehydrase: effect of AMP on an early stp in the reaction mechanism. Biochemical and Biophysical Research Communications 36(6): 951-956
Grzelakowska-Sztabert, B.; Rytka, J. 1968: Allosteric control of biological activity of some proteins. Postepy Biochemii 14(2): 251-266
Klemme, J.H. 1973: Allosteric control of pyruvate kinase from Rhodospirillum rubrum by inorganic phosphate and sugar phosphate esters. Archiv für Mikrobiologie 90(4): 305-322
Sanwal, B.D. 1970: Allosteric controls of amphilbolic pathways in bacteria. Bacteriological Reviews 34(1): 20-39
Rothman, R.B.; Westfall, T.C. 1982: Allosteric coupling between morphine and enkephalin receptors in vitro. Molecular Pharmacology 21(3): 548-557
Imabori, K. 1970: Allosteric effect in protein synthesis. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 15(13): 1362-1366
Louie, D.D.; Kaplan, N.O.; McLean, J.D. 1972: Allosteric effect of 2'-adenylic acid on the Pseudomonas pyridine nucleotide transhydrogenase. Journal of Molecular Biology 70(3): 651-664
Bonewell, G.; Rossini, L. 1966: Allosteric effect of dinitrophenol and protein digestion. Bollettino della Societa Italiana di Biologia Sperimentale 42(20): 1426-1428
Maeda, T. 1970: Allosteric effector of hemoglobin, D-2,3-diphosphoglycerate. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 15(13): 1328-1332
Shimizu, K.; Bucci, E. 1974: Allosteric effectors of hemoglobin. Interaction of human adult and fetal hemoglobins with poly(carboxylic acids). Biochemistry 13(4): 809-814
Tokushige, M. 1970: Allosteric effects and metabolic regulation. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 15(13): 1333-1341
Semenza, G.; Rihová, L. 1969: Allosteric effects and phlorizin inhibition of intestinal trehalase. Biochimica et Biophysica Acta 178(2): 393-396
Larsson, A.; Reichard, P. 1966: Allosteric effects and substrate specificity of the ribonucleoside diphosphate reductase system from Escherichia coli B. Biochimica et Biophysica Acta 113(2): 407-408
Tokushige, M. 1970: Allosteric effects in threonine deaminases. Seikagaku. Journal of Japanese Biochemical Society 42(12): 887-903
Lenger, K. 1983: Allosteric effects of cortisol, estradiol, progesterone and of the DNA-sequences poly d(A-T) and poly d(C-G) on the adenosine and thymidine phosphorylating activity of the nuclear nucleoside-nucleotide phosphotransferase C. International Journal of Biochemistry 15(10): 1241-1248
Kvamme, E. 1970: Allosteric enzymes. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(2): 184-190
Weitzman, P.D. 1967: Allosteric fine control of citrate synthase in Escherichia coli. Biochimica et Biophysica Acta 139(2): 526-528
Ono, K.; Iwata, Y.; Nakane, H. 1982: Allosteric inhibition by aphidicolin of the activity of DNA polymerase alpha from mouse myeloma. Nucleic Acids Symposium Series 11: 157-160
Jensen, R.A.; Calhoun, D.H.; Stenmark, S.L. 1973: Allosteric inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase by tyrosine, tryptophan and phenylpyruvate in Pseudomonas aeruginosa. Biochimica et Biophysica Acta 293(1): 256-268
Mager, P.P. 1974: Allosteric inhibition of L-glutamic acid decarboxylase by valine in rat brain. Activitas Nervosa Superior 16(1): 19-20
Vidal, M.C.; Cazzulo, J.J. 1972: Allosteric inhibition of NADP-linked malic enzyme from an extreme halophile by acetyl-CoA. Febs Letters 26(1): 257-260
Haworth, R.A.; Hunter, D.R. 1980: Allosteric inhibition of the Ca2+-activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. Journal of Membrane Biology 54(3): 231-236
De Meis, L. 1971: Allosteric inhibiton by alkali ions of the Ca 2+ uptake and adenosine triphosphatase activity of skeletal muscle microsomes. Journal of Biological Chemistry 246(15): 4764-4773
Nikol'skaia, E.B. 1971: Allosteric interaction between substrate and enzyme. Doklady Akademii Nauk SSSR 200(1): 237-239
Johnson, J.D. 1983: Allosteric interactions among drug binding sites on calmodulin. Biochemical and Biophysical Research Communications 112(2): 787-793
Tobin, T.; Banerjee, S.P.; Sen, A.K. 1970: Allosteric interactions in (Na+ plus K+)-ATPase. Nature 225(5234): 745-746
Grillo, M.A.; Fossa, T. 1971: Allosteric interactions in D-serine dehydratase of chicken kidney. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 352(6): 791-796
Stroinski, A.; Pawelkiewicz, J.; Johnson, B.C. 1974: Allosteric interactions in glycerol dehydratase. Purification of enzyme and effects of positive and negative cooperativity for glycerol. Archives of Biochemistry and Biophysics 162(2): 321-330
Bresler, S.; Firsov, L. 1971: Allosteric interactions in phosphorylase B. Biopolymers 10(7): 1187-1205
Lorek, A.; Wilson, K.S.; Sansom, M.S.; Stuart, D.I.; Stura, E.A.; Jenkins, J.A.; Zanotti, G.; Hajdu, J.; Johnson, L.N. 1984: Allosteric interactions of glycogen phosphorylase b. a crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b. Biochemical Journal 218(1): 45-60
Wieker, H.J.; Hess, B. 1971: Allosteric interactions of yeast pyruvate kinase as a function of pH. Biochemistry 10(7): 1243-1248
Whitehead, E.P. 1967: Allosteric kinetics of inhibition of the 1st enzyme for the biosynthesis of histidine in S. pombe. Bulletin de la Societe de Chimie Biologique 49(11): 1529-1535
Johannes, K.J.; Hess, B. 1973: Allosteric kinetics of pyruvate kinase of Saccharomyces carlsbergensis. Journal of Molecular Biology 76(2): 181-205
Rang, H.P. 1973: Allosteric mechanisms at neuromuscular junctions. Neurosciences Research Program Bulletin 11(3): 220-224
Janssen, L.H.; de Bruin, S.H. 1973: Allosteric models for the interaction of 2,3-diphosphoglyceric acid with hemoglobin. International Journal of Peptide and Protein Research 5(1): 27-31
Asai, H. 1970: Allosteric models of hemoglobins of the lower animals. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 15(13): 1321-1327
Schoemaker, H.; Boles, R.G.; Roeske, W.R.; Yamamura, H.I. 1983: Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain. Proceedings of the Western Pharmacology Society 26: 219-224
Rothman, R.B.; Westfall, T.C. 1981: Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain. European Journal of Pharmacology 72(4): 365-368
Katsunuma, T.; Temma, M.; Katunuma, N. 1968: Allosteric nature of a glutaminase isozyme in rat liver. Biochemical and Biophysical Research Communications 32(3): 433-437
Zirancic, A.O. 1971: Allosteric nature of the membrane-bound acetylcholinesterase as the basis for the cholinoreceptor function of this enzyme. Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 24: 37-41
Yoshida, M. 1972: Allosteric nature of thermostable phosphofructokinase from an extreme thermophilic bacterium. Biochemistry 11(6): 1087-1093
Alpers, J.B.; Paulus, H. 1971: Allosteric preconditioning: role of allosteric ligands in promoting the maturation of enzymes. Nature 233(5320): 478-480
Mal'ian, A.N. 1980: Allosteric properties of CF1-ATPase form chloroplasts. Biokhimiia 45(10): 1731-1739
Bailin, G.; Lukton, A. 1966: Allosteric properties of a phosphorylase alpha-glutamic-pyruvic transaminase complex. Biochimica et Biophysica Acta 128(2): 317-326
Marco, R.; Carbonell, J.; Llorente, P. 1971: Allosteric properties of adipose tissue pyruvate kinase. Biochemical and Biophysical Research Communications 43(1): 126-132
Lee, T.C.; Gibson, Q.H. 1981: Allosteric properties of carbamylated hemoglobins. Journal of Biological Chemistry 256(9): 4570-4577
Benenson, A.M.; Shpikiter, V.O. 1971: Allosteric properties of cathepsin C in neutral medium. Biulleten' Eksperimental'noi Biologii i Meditsiny 72(8): 49-51
Dolgo-Saburov, V.B.; Mukhamedzhanov, E.K. 1972: Allosteric properties of cholinesterases. Ukrains'kyi Biokhimichnyi Zhurnal 44(3): 400-405
Sumi, T.; Ui, M. 1972: Allosteric properties of enzymes with "ping-pong" mechanism. Biochimica et Biophysica Acta 276(1): 12-18
Wang, J.H.; Tu, J.I. 1970: Allosteric properties of glutaraldehyde-modified glycogen phosphorylase b. Selective desensitization of homotropic cooperativity. Journal of Biological Chemistry 245(1): 176-182
Kagan, Z.S.; Ignat'eva, L.I. 1971: Allosteric properties of meso-alpha, epsilon diaminopimelic acid decarboxylase in the lysine-accumulating strain of Brevibacterium-22. Doklady Akademii Nauk SSSR 197(5): 1196-1199
Mathias, M.M.; Kemp, R.G. 1972: Allosteric properties of muscle phosphofructokinase. 3. Thiol reactivity as an indicator of conformational state. Biochemistry 11(4): 578-584
Kemp, R.G. 1969: Allosteric properties of muscle phosphofructokinase. I. Binding of magnesium adenosine triphosphate to the inhibitory site. Biochemistry 8(8): 3162-3168
Kemp, R.G. 1969: Allosteric properties of muscle phosphofructokinase. II. Kinetics of native and thiol-modified enzyme. Biochemistry 8(11): 4490-4496
Snodgrass, P.J.; Lund, P. 1984: Allosteric properties of phosphate-activated glutaminase of human liver mitochondria. Biochimica et Biophysica Acta 798(1): 21-27
Blangy, D. 1971: Allosteric properties of phosphofructokinase of E. coli. Study of the ligand binding by equilibrium dialysis. Biochimie 53(2): 135-144
Chiang, P.K. 1971: Allosteric properties of rabbit triosephosphate isomerase. Life Sciences.(Part 2): Biochemistry General and Molecular Biology 10(14): 831-839
Tejwani, G.A.; Mousa, S. 1981: Allosteric properties of rat lung phosphofructokinase. Enzyme 26(6): 306-314
Kretovich, V.L.; Loseva, L.P. 1973: Allosteric properties of the biosynthetic L-threonine dehydratase from Azotobacter vinelandii. Mikrobiologiia 42(5): 772-778
Costa, L.; De Asúa, L.J.; Rozengurt, E.; Bade, E.G.; Carminatti, H. 1972: Allosteric properties of the isoenzymes of pyruvate kinase from rat kidney cortex. Biochimica et Biophysica Acta 289(1): 128-136
Dröge, J.H.; Janssen, L.H.; Wilting, J. 1983: Allosteric properties of the oxyphenbutazone--human serum albumin complex. Pharmaceutisch Weekblad. Scientific Edition 5(5): 228-233
Yon, R.J. 1971: Allosteric properties of wheat-germ aspartate transcarbamoylase. Biochemical Journal 124(2): 10P-11P
Ferry, D.R.; Malkhandi, P.J.; Russell, M.A.; Kerr, D.J. 1995: Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine. Biochemical Pharmacology 49(12): 1851-1861
Stalon, V.; Wiame, J.M.; Piérard, A. 1970: Allosteric regulation of catabolic ornithine carbamoyltransferase from Pseudomonas fluorescens. Kinetic study. Archives Internationales de Physiologie et de Biochimie 78(1): 179-180
Halleux, P.; Stalon, V.; Piérard, A.; Wiame, J.M. 1970: Allosteric regulation of catabolic ornithine carbamoyltransferase of Pseudomonas fluorescens. Quartenary structure. Archives Internationales de Physiologie et de Biochimie 78(1): 166-168
Vergnano, C.; Cartasegna, C.; Matteini, M. 1968: Allosteric regulation of delta-aminolevulinic dehydratase activity. Ii. Bollettino della Societa Italiana di Biologia Sperimentale 44(7): 695-699
Stadtman, E.R. 1966: Allosteric regulation of enzyme activity. Advances in Enzymology and Related Areas of Molecular Biology 28: 41-154
Kirschner, K. 1968: Allosteric regulation of enzyme activity. An introduction to the molecular basis of and the experimental approaches to the problem. Current Topics in Microbiology and Immunology 44: 123-146
Vergnano, C.; Cartasegna, C.; Bonsignore, D. 1968: Allosteric regulation of erythrocyte delta-aminolevulinic dhydratase activity. Bollettino della Societa Italiana di Biologia Sperimentale 44(7): 692-695
Sharaev, P.N.; Bogdanov, N.G.; Sarycheva, I.K.; Zhukova, E.E. 1981: Allosteric regulation of glucosamine synthetase activity by naphthoquinone derivatives and ethyl ester of di-(4-oxycumarinyl-3)-acetic acid. Biokhimiia 46(2): 342-346
Malik, M.N.; Detwiler, T.C.; Stracher, A. 1973: Allosteric regulation of platelet actomyosin. Biochemical and Biophysical Research Communications 55(3): 912-918
Tullson, P.; Goldstein, L. 1982: Allosteric regulation of renal alpha-ketoglutarate dehydrogenase. Contributions to Nephrology 31: 122-126
Johnson, E.F.; Schwab, G.E.; Dieter, H.H. 1983: Allosteric regulation of the 16 alpha-hydroxylation of progesterone as catalyzed by rabbit microsomal cytochrome P-450 3b. Journal of Biological Chemistry 258(5): 2785-2788
Grissom, C.B.; Canellas, P.F.; Wedding, R.T. 1983: Allosteric regulation of the NAD malic enzyme from cauliflower: activation by fumarate and coenzyme a. Archives of Biochemistry and Biophysics 220(1): 133-144
Canellas, P.F.; Grissom, C.B.; Wedding, R.T. 1983: Allosteric regulation of the NAD malic enzyme from cauliflower: activation by sulfate. Archives of Biochemistry and Biophysics 220(1): 116-132
Wright, J.A.; Maeba, P.; Sanwal, B.D. 1967: Allosteric regulation of the activity of citrate snythetase of Escherichia coli by alpha-ketoglutarate. Biochemical and Biophysical Research Communications 29(1): 34-38
Preiss, J.; Greenberg, E. 1969: Allosteric regulation of uridine diphosphoglucose: D-fructose-6-phosphate-2-glucosyl transferase (E.C. Biochemical and Biophysical Research Communications 36(2): 289-295
Kemp, R.G.; Foe, L.G. 1983: Allosteric regulatory properties of muscle phosphofructokinase. Molecular and Cellular Biochemistry 57(2): 147-154
Furuichi, Y. 1981: Allosteric stimulatory effect of S-adenosylmethionine on the RNA polymerase in cytoplasmic polyhedrosis virus. a model for the positive control of eukaryotic transcription. Journal of Biological Chemistry 256(1): 483-493
Shimizu, H. 1970: Allosteric transition and biotic movement. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 15(13): 1288-1298
Gibson, Q.H.; Nagel, R.L. 1974: Allosteric transition and ligand binding in hemoglobin Chesapeake. Journal of Biological Chemistry 249(22): 7255-7259
Maley, G.F.; Maley, F. 1982: Allosteric transitions associated with the binding of substrate and effector ligands to T2 phage induced deoxycytidylate deaminase. Biochemistry 21(16): 3780-3785
Blangy, D.; Buc, H. 1967: Allosteric transitions of phosphofructokinase of E. coli and phosphorylase B of rabbitmuscle. Bulletin de la Societe de Chimie Biologique 49(11): 1473-1478
Moraru, I.; Scărlătescu, M. 1968: Allosterie transition. Fiziologia Normala Si Patologica 14(2): 97-108
Schoffeniels, E. 1970: Allosterism and permeability of cell membranes. Archives Internationales de Physiologie et de Biochimie 78(2): 205-223
Sitaramayya, A.; Krishnan, P.S. 1970: Allosterism in rat brain supernatant guanine deaminase. Biochemical and Biophysical Research Communications 40(3): 565-569
Schoffeniels, E. 1972: Allostery and permeability of postsynaptic membranes. Biomembranes 3: 499-513
Jensen, R.A.; Twarog, R. 1972: Allostery of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase in Clostridium: another conserved generic characteristic. Journal of Bacteriology 111(3): 641-648
Zamoyska, R.; Waldmann, H. 1984: Allosuppression: evidence for the involvement of both "noncytotoxic" and cytotoxic T cells. European Journal of Immunology 14(7): 645-651
Topliss, D.J.; Okita, N.; Lewis, M.; Row, V.V.; Volpé, R. 1981: Allosuppressor T lymphocytes abolish migration inhibition factor production in autoimmune thyroid disease: evidence from radiosensitivity experiments. Clinical Endocrinology 15(4): 335-341
Pals, S.T.; Gleichmann, H.; Gleichmann, E. 1984: Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells. Journal of Experimental Medicine 159(2): 508-523
Rolink, A.G.; Pals, S.T.; Gleichmann, E. 1983: Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. Journal of Experimental Medicine 157(2): 755-771
Pals, S.T.; Radaszkiewicz, T.; Gleichmann, E. 1984: Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD. Journal of Immunology 132(4): 1669-1678
Rolink, A.G.; Gleichmann, E. 1983: Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. Journal of Experimental Medicine 158(2): 546-558
Efimov, V.N. 1981: Allotendinoplasty in knee joint injuries. Vestnik Khirurgii Imeni I. I. Grekova 126(2): 100-103
Nikitin, G.D.; Nabieva, T.A. 1981: Allotendoplasty in the complex surgery of transverse flatfoot. Vestnik Khirurgii Imeni I. I. Grekova 126(6): 76-80
Johansson, H. 1968: Meditations of a student nurse. Tidskrift for Sveriges Sjukskoterskor 8: 403
Ferrer, J. 1968: Allotment of time. Boletin de Informacion - Ilustre Colegio Oficial de Odontologos y Estomatologos 2. a Region 12(78): 9-16
Tipton, K.F.; Houslay, M.D.; Garrett, N.J. 1973: Allotopic properties of human brain monoamine oxidase. Nature: New Biology 246(155): 213-214
Milgrom, F. 1980: Allotransplantation and autoimmunity. Transplantation Proceedings 12(4): 557-565
Tze, W.J.; Tai, J. 1984: Allotransplantation and xenotransplantation of pseudoislets in diabetic rats and mice. Transplantation 38(4): 438-440
Nadler, H.L. 1972: Allotransplantation for the treatment of inborn errors of metabolism. Annals of Internal Medicine 77(2): 314-316
Pávková, L.; Konícková, Z.; Böhm, F.; Dvorák, R.; Svoboda, S.; Königová, R. 1980: Allotransplantation in burns. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 59(5): 330-333
Polezhaev, L.V.; Aleksandrova, M.A. 1983: Allotransplantation of embryonic brain tissue into the brains of adult mammals during hypoxic hypoxia. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(7): 990-997
Chen, Z.W. 1983: Allotransplantation of freeze-dried vessels in dogs. Zhonghua Wai Ke Za Zhi 21(4): 217-219
Sollinger, H.W.; Mack, E.; Cook, K.; Belzer, F.O. 1983: Allotransplantation of human parathyroid tissue without immunosuppression. Transplantation 36(6): 599-602
Nishino, H. 1984: Allotransplantation of isolated pancreatic islets in diabetic rats. Effect of culture on islet rejection. Nihon Geka Gakkai Zasshi 85(1): 38-48
Volkov, M. 1970: Allotransplantation of joints. Journal of Bone and Joint Surgery. British Volume 52(1): 49-53
Hu, J.M. 1980: Allotransplantation of knee joint: a case report. Zhonghua Wai Ke Za Zhi 18(4): 349
Blumenstock, D.A.; Kazemi, H.; Hales, C.A.; Cannon, F.D.; Zumwalt, R.; Ferrebee, J. 1974: Allotransplantation of lung without immunosuppression after transplantation. I. Staged transplantation of bone marrow and lung. Transplantation 18(4): 336-342
Dobroschke, J.; Schwemmle, K.; Langhoff, G.; Bretzel, R.G. 1983: Allotransplantation of neonatal pancreas-microfragments in man. Hormone and Metabolic Research. Suppl Series 13: 91-93
Decker, G.A.; Stark, J.H.; Botha, J.R.; Margolius, L.P.; Decker, G. 1995: Allotransplantation of parathyroid cells. Lancet 345(8942): 124
Gong, E.H. 1982: Allotransplantation of parathyroid glands from the fetus: report of 6 cases. Zhonghua Wai Ke Za Zhi 20(12): 742
Chen, G.R. 1981: Allotransplantation of parathyroid glands with vascular anastomosis: report of 6 cases. Zhonghua Wai Ke Za Zhi 19(8): 470-473
Nordenram, A. 1967: Allotransplantation of teeth. Den Norske Tannlaegeforenings Tidende 77(4): 187-197
Nordenram, A.; Björnesjö, K.B. 1970: Allotransplantation of teeth in man on the basis of the Normal Lymphocyte Transfer (NLT) test. Odontologisk Revy 21(2): 169-188
Raĭnov, R.V. 1971: Allotransplantation of the esophagus. Eksperimental'naia Khirurgiia i Anesteziologiia 16(3): 11-15
Blumenstock, D.; Wells, E.; Sanford, C.; DeGillio, M. 1971: Allotransplantation of the lung in beagle and mongrel dogs prospectively typed for lymphocytic antigens. Transplantation 11(2): 192-194
Kelly, W.D.; Lillehei, R.C.; Merkel, F.K.; Idezuki, Y.; Goetz, F.C. 1967: Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61(6): 827-837
Ota, K.; Mori, S.; Nobori, M.; Inou, T. 1967: Allotransplantation of the pancreas in dogs. Journal of Surgical Research 7(5): 207-214
Wykoff, T.W.; Jones, R.D. 1971: Allotransplantation of the thyroid cartilage in dogs. Surgical Forum 22: 463-464
Kobayashi, E.; Miyata, M. 1995: Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia a. Archives of Surgery 130(6): 676-677
Liu, D.L.; Xia, S.; Tang, J.; Qin, X.; Liu, H. 1995: Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results. Archives of Surgery 130(1): 33-39
Mann, E. 1970: Allotransplantation--common infections of the mouth and pharynx. Zwr 79(9): 289-291
Vellekamp, G.J.; Kull, F.J. 1981: Allotropism in aspartyl-tRNA synthetase from procine thyroid. European Journal of Biochemistry 118(2): 261-269
Ivanyi, J.; Makings, C. 1980: Allotype analysis of histocompatible and semiallogeneic B cell chimeric chickens. Transplantation 29(1): 25-29
Notenboom, R.H.; Dubiski, S.; Cinader, B.; Good, P.W. 1982: Allotype and charge-related differences in the immune response. Journal of Immunogenetics 9(2): 101-110
Oudin, J. 1972: Allotype and idiotype. Memoires de l'Academie Royale de Medecine de Belgique 7(6): 425-438
Skałba, D.; Anasz, Z.; Falkus, J.; Polak, S. 1982: Allotype determinants of the beta lipoprotein fraction (blood donor sera). Wiadomosci Lekarskie 35(21): 1335-1339
Kindt, T.J.; Todd, C.W.; Eichmann, K.; Krause, R.M. 1970: Allotype exclusion in uniform rabbit antibody to streptococcal carbohydrate. Journal of Experimental Medicine 131(2): 343-354
Cinader, B.; Koh, S.W.; Kuksin, P. 1974: Allotype levels in normal and allotype suppressed mice after allogeneic stimulation. Cellular Immunology 11(1-3): 170-187
Litwin, S.D. 1973: Allotype preference in human Rh antibodies. Journal of Immunology 110(3): 717-721
Vice, J.L.; Gilman-Sachs, A.; Hunt, W.L.; Dray, S. 1970: Allotype suppression in alpha-2alpha-2 homozygous rabbits fostered in uteri of alpha-2-immunized alpha-1alpha-1 homozygous mothers and injected at birth with anti-alpha-2 antiserum. Journal of Immunology 104(3): 550-554
Curling, E.M.; Dresser, D.W. 1984: Allotype suppression in an adoptive transfer system in adult mice: the specificity and feedback effects of a monoclonal IgG3 anti-(Igh-1b) allotype antibody. Immunology 51(3): 511-516
Ratcliffe, M.J.; Ivanyi, J. 1981: Allotype suppression in the chicken. II. Suppression in homozygous chickens with antiallotype antibody and allotype-disparate B cells. European Journal of Immunology 11(4): 296-300
Ratcliffe, M.J.; Ivanyi, J. 1981: Allotype suppression in the chicken. III. Analysis of the recovery form suppression by neonatally injected or maternal antibodies. European Journal of Immunology 11(4): 301-306
Ratcliffe, M.J.; Ivanyi, J. 1981: Allotype suppression in the chicken. IV. Deletion of B cells and lack of suppressor cells during chronic suppression. European Journal of Immunology 11(4): 306-310
Ratcliffe, M.J. 1984: Allotype suppression in the chicken. V. Abnormal isotype ratios of chronically suppressed IgM and IgG allotypes. Cellular Immunology 83(1): 208-214
Harrison, M.R.; Mage, R.G. 1973: Allotype suppression in the rabbit. I. the ontogeny of cells bearing immunoglobulin of paternal allotype and the fate of these cells after treatment with antiallotype antisera. Journal of Experimental Medicine 138(4): 764-774
Lee, S.K.; Dresser, D.W. 1981: Allotype suppression of the responsiveness of adoptively transferred adult spleen cells induced by affinity prepared anti-allotype antibody. Immunology 42(4): 601-610
Vice, J.L.; Hunt, W.L.; Dray, S. 1969: Allotype suppression with anti-b5 antiserum in b5b5 homozygous rabbits fostered in uteri of b4b4 homozygous mothers: compensation by allotypes at other loci. Journal of Immunology 103(4): 629-638
Khattab, M.S.; Craig, J.V. 1970: Allotype synthesis by adult donors' leukocytes and spleen cells injected into newly hatched chicks. Transplantation 10(1): 33-43
Craig, J.V.; Polley, C.R. 1972: Allotype synthesis by transplanted embryonic spleen cells in chickens. Transplantation 14(3): 388-391
Dreher, K.L.; Sogn, J.A.; Gates, F.T.; Kuo, M.C.; Kindt, T.J. 1983: Allotype-defined mRNA for rabbit immunoglobulin H and L chains isolated from rabbit-mouse hybridomas. Journal of Immunology 130(1): 442-448
Neriah, Y.B.; Givol, D.; Lonai, P.; Simon, M.M.; Eichmann, K. 1980: Allotype-linked genetic control of a polymorphic VH framework framework determinant on mouse T-helper cell receptors. Nature 285(5762): 257-259
Huang, L.S.; Jaeger, J.S.; Usher, D.C. 1983: Allotypes associated with B apolipoproteins in rabbits. Journal of Lipid Research 24(11): 1485-1493
Binz, H.; Lindenmann, J. 1974: Allotypes of anti-alloantibodies. Cellular Immunology 10(2): 260-266
Fine, J.M. 1970: Allotypes of human albumin. Study of 8 cases of bisalbuminemia observed in France. Revue Europeenne d'Etudes Cliniques et Biologiques. European Journal of Clinical and Biological Research 15(1): 113-118
Ito, C.; Fukuoka, Y.; Ogata, Y.; Matsumoto, H. 1974: Allotypes of immunoglobulins in HB antigen- and HB antibody-positive patients. Rinsho Byori. Japanese Journal of Clinical Pathology 22(10 Suppl): 171
Nezlin, R.S.; Rokhlin, O.V.; Vengerova, T.I. 1974: Allotypes of light chains of rat immunoglobulins. Annales d'Immunologie 125c (1-2): 93-95
Natsuume-Sakai, S.; Kaidoh, T.; Sudo, K.; Takahashi, M. 1984: Allotypes of murine factor B controlled by a locus within the S region of the H-2 complex. Journal of Immunology 133(2): 830-834
Grodecka, U. 1968: Allotypes of rabbit gamma globulins and their significance in immunology. Postepy Higieny i Medycyny Doswiadczalnej 22(5): 799-840
Beckers, A.; Querinjean, P.; Bazin, H. 1974: Allotypes of rat immunoglobulins. II. Distribution of the allotypes of kappa and alpha chain loci in different inbred strains of rats. Immunochemistry 11(9): 605-609
Strejcek, J.; Herzog, P. 1966: Allotypes of serum immunoglobulins in systemic lupus erythematosus. Sbornik Lekarsky 68(6): 185-190
De Vries, G.M. 1972: Allotypic activity of halves of rabbit immunoglobulin L chains. Archives Internationales de Physiologie et de Biochimie 80(5): 965-966
Van Loghem, E.; Biewenga, J. 1983: Allotypic and isotypic aspects of human immunoglobulin a. Molecular Immunology 20(9): 1001-1007
Le Petit, J.C.; Brizard, C.P. 1971: Allotypic and isotypic determination of auto-antibodies in IgG haemolytic anemias. Nouvelle Revue Francaise d'Hematologie 11(2): 255-260
Leslie, G.A. 1984: Allotypic determinants (Igh-3) associated with the IgG2c subclass of rat immunoglobulins. Molecular Immunology 21(7): 577-580
Skałba, D.; Zurowska, I.; Anasz, Z.; Falkus, J.; Polak, S. 1982: Allotypic determinants of the beta-lipoprotein fraction (sera of newborn infants). Wiadomosci Lekarskie 35(22): 1407-1410
Knight, K.L.; Gilman-Sachs, A.; Fields, R.; Dray, S. 1971: Allotypic determinants on the Fab fragment of rabbit Aa locus negative IgG-immunoglobulin. Journal of Immunology 106(3): 761-767
Ferrarini, M.; Kent, S.P.; Munro, A.; Kelus, A.S.; Catty, D.; Coombs, R.R. 1973: Allotypic determinants on the surface of rosette-forming cells in the rabbit. European Journal of Immunology 3(4): 213-218
Brizard, C.P.; Le Petit, J.C.; Rivat, L.; Ropartz, C. 1970: Allotypic determination of auto-antibodies in haemolytic anaemias. Revue Europeenne d'Etudes Cliniques et Biologiques. European Journal of Clinical and Biological Research 15(10): 1113-1115
Kelus, A.S. 1969: Allotypic marker GP-gamma-2-I of guinea-pig immunoglobulins. Nature 223(5204): 398-399
Nezlin, R.S.; Vengerova, T.I.; Rokhlin, O.V.; Machulla, H.K. 1974: Allotypic marker of kappa light chains of rat immunoglobulins localized in the constant region of the chain. Immunochemistry 11(8): 517-518
Kelus, A.S.; Pernis, B. 1971: Allotypic markers of rabbit IgM. European Journal of Immunology 1(2): 123-132
Kruisbeek, A.M.; Rádl, J.; Swart, A.C. 1974: Allotypic markers of rhesus monkey immunoglobulin G. European Journal of Immunology 4(6): 448-450
De Benedictis, G.; Dragone, A.; Brancati, C.; Tagarelli, A. 1983: Allotypic phenotypes displaying different frequencies in healthy and beta-thalassemic sample populations. Immunology Letters 6(2): 73-79
Sanchez, P.; Juy, D.; Cazenave, P.A. 1983: Allotypic restriction of the expression of MOPC460 idiotope after immunization with either anti-2,4-dinitrophenyl (DNP) or anti-idiotypic antibodies. European Journal of Immunology 13(12): 999-1003
Trávnícek, J. 1966: Allotypic specificities in pigs. II. Types of frequency of allotypic specificities of gamma M globulin in pigs. Folia Microbiologica 11(5): 406-407
Stall, A.M.; Loken, M.R. 1984: Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies. Journal of Immunology 132(2): 787-795
Fujiwara, M. 1970: Allotypic specificity of immunological tolerance: a study on the termination. Japanese Journal of Experimental Medicine 40(5): 395-399
Dubiski, S.; Swierczynska, Z. 1971: Allotypic suppression in rabbits. Operational characterization of the target cells. International Archives of Allergy and Applied Immunology 40(1): 1-18
Anderson, H.R. 1970: Allotypic suppression of adult mouse spleen cells. Immunology 19(1): 169-179
Anderson, H.R. 1972: Allotypic suppression of adult mouse spleen cells: cell differentiation, class restriction and allotypic exclusion. European Journal of Immunology 2(1): 11-18
McIntyre, J.A.; Faulk, W.P. 1982: Allotypic trophoblast-lymphocyte cross reactive (TLX) antigens. Progress in Clinical and Biological Research 85 Pt A: 463-472
McIntyre, J.A.; Faulk, W.P. 1982: Allotypic trophoblast-lymphocyte cross-reactive (TLX) cell surface antigens. Human Immunology 4(1): 27-35
Davrinche, C.; Rivat, C.; Rivat-Peran, L. 1981: Allotypic variants of human C3 and properdin factor B in two French populations Normans and Basques. Revue Francaise de Transfusion et Immuno-Hematologie 24(3): 309-317
Chersi, A.; Mage, R. 1980: Allotypic variations in the amino acid sequence of rabbit IgG kappa light chains in the region of tryptophan 146. Molecular Immunology 17(1): 135-138
Mole, L.E.; Jackson, S.A.; Porter, R.R.; Wilkinson, J.M. 1971: Allotypically related sequences in the Fd fragment of rabbit immunoglobulin heavy chains. Biochemical Journal 124(2): 301-318
Ropartz, C. 1974: Allotyping of human immunoglobulins. Annales d'Immunologie 125c (1-2): 27-39
Ropartz, C. 1971: Allotypy and isotypy of human gamma G. Revue Francaise de Transfusion 14(1): 25-38
Porter, R.R. 1974: Allotypy and structure of immunoglobulins. Annales d'Immunologie 125c (1-2): 85-91
Berg, K.; Boman, H.; Torsvik, H.; Walker, S.M. 1971: Allotypy of high density lipoprotein of rabbit serum. Proceedings of the National Academy of Sciences of the United States of America 68(5): 905-908
Todd, C.W. 1974: Allotypy of rabbit immunoglobulins. Annales d'Immunologie 125c (1-2): 15-26
Dunn, R.W. 1995: Allow physicians who commit sex offences to work, but away from patients. Cmaj: Canadian Medical Association Journal 153(9): 1228
Björck, S. 1973: Allow the student to take care of the right patient by herself. Tidskrift for Sveriges Sjukskoterskor 40(18): 12-14
Fu, W.Z. 1981: Allowable concentration of carbon disulfide vapor in workshop. Zhonghua Yu Fang Yi Xue Za Zhi 15(4): 204-207
Gassovskiĭ, L.N.; Dmitrieva, A.M.; Krivoshapova, L.V. 1971: Allowable errors in the adjustment of spectacle lenses with respect to eyes adapted to ready-made glasses. Vestnik Oftalmologii 4: 87-89
Whillans, G. 1968: Allowable expenses for holders of an office. Practitioner 1968: Suppl. 6: 34-5
Hunter, C.G. 1968: Allowable human body concentrations of organochlorine pesticides. La Medicina del Lavoro 59(10): 577-583
Moskalev, I.I.; Shtukkenberg, I.M.; Zhuravlev, V.F. 1968: Allowable levels of tritium oxide with diagnostic purpose in humans. Meditsinskaia Radiologiia 13(6): 82-85
Ishihara, M.; Osawa, T. 1971: Allowable limit in clinical laboratory tests for pregnant women. Sanfujinka no Jissai. Practice of Gynecology and Obstetrics 20(12): 1141-1146
Wolpert, L. 1971: Positional information and pattern formation. Current Topics in Developmental Biology 6(6): 183-224
Vologodskii, A.V.; Amirikyan, B.R.; Lyubchenko, Y.L.; Frank-Kamenetskii, M.D. 1984: Allowance for heterogeneous stacking in the DNA helix-coil transition theory. Journal of Biomolecular Structure and Dynamics 2(1): 131-148
Machácová, E. 1984: Allowance for the care of a family member--its social significance. Ceskoslovenske Zdravotnictvi 32(12): 524-532
Dombrovskaia, M.P.; Demina, S.E.; Shumilova, S.L.; Smirnov, N.M.; Bogdano, N.G. 1982: Allowance of ascorbic acid and individual B group vitamins for schoolchildren. Voprosy Pitaniia 1: 70
Damiani, A.; De Santis, P.; Pizzi, A. 1970: Allowed conformations of alanyl preceding prolyl residues. Nature 226(5245): 542-543
Hollings, L. 1995: Allowed to die. Nursing Standard: 1987) 10(4): 40
Sivieri, M.C.; de Paula, N.S. 1968: Allowing for instruction in the performance of laboratory tests and examination by the nurse. Revista da Escola de Enfermagem da U S P 2(2): 12-19
Brower, H.T. 1995: Allowing for same sex preferences. Journal of Gerontological Nursing 21(9): 5-6
Phillips, K. 1995: Allowing parents or carers into the anaesthetic room when a child is having an operation. British Journal of Theatre Nursing: Natnews: the Official Journal of the National Association of Theatre Nurses 4(11): 28-29
Parks, S.L. 1966: Allowing physical distance as a nursing approach. Perspectives in Psychiatric Care 4(6): 31-35
Anonymous 1983: Allowing the debilitated to die. New England Journal of Medicine 309(14): 862-863
Paulshock, B.Z.; Stitz, K. 1984: Allowing the debilitated to die. Journal of Family Practice 18(6): 945-946
Adams, W.E.; Heindel, N.D.; Tutwiler, G.; Fawthrop, H. 1984: Alloxan analogues as potential pancreatic-imaging radiopharmaceuticals. Journal of Pharmaceutical Sciences 73(3): 394-396
Cohen, G.; Heikkila, R.E. 1984: Alloxan and 6-hydroxydopamine: cellular toxins. Methods in Enzymology 105: 510-516
Ishibashi, F.; Howard, B.V. 1981: Alloxan and H2O2 action on glucose metabolism in cultured fibroblasts. Generation of oxygen-containing free radicals as a mechanism of alloxan action. Journal of Biological Chemistry 256(23): 12134-12139
Graymore, C.; Ashton, N.; McCormick, A. 1968: Alloxan and lactic acid dehydrogenase activity of the cornea. British Journal of Ophthalmology 52(9): 677-681
Edström, C.; Boquist, L. 1973: Alloxan diabetes in duct-ligated rats. Light and electron microscopic findings. Acta Pathologica et Microbiologica Scandinavica. Section A Pathology 81(1): 47-56
Sutter, M.T.; Félix, J.M.; Jacquot, R.; Sutter, B.C. 1970: Alloxan diabetes in pregnant rats and in fetus. Journal de Physiologie 62(Suppl 1): 219-220
McLetchie, N.G. 1982: Alloxan diabetes: the sorcerer and his apprentice. Diabetologia 23(1): 72-75
Boquist, L. 1984: Alloxan effects on mitochondria in vitro: correlation between endogenous adenine nucleotides and efflux of Ca2+. Biochemistry International 9(5): 637-641
Boquist, L. 1984: Alloxan effects on mitochondria: study of oxygen consumption, fluxes of Mg2+, Ca2+, K+ and adenine nucleotides, membrane potential and volume change in vitro. Diabetologia 27(3): 379-386
Jacobson, B.S.; Smith, B.N.; Jacobson, A.V. 1972: Alloxan induced change from carbohydrate to lipid oxidation in rats determined by the prevalence of carbon-13 in expired carbon dioxide. Biochemical and Biophysical Research Communications 47(2): 398-402
Emmrich, P.; Schade, J.; von Lengerken, G.; Heilmann, W.; Penndorf, H.; Hennebach, H. 1982: Alloxan induced long term diabetes in the domestic pig. i. Endokrinologie 80(2): 220-230
Dean, P.M.; Matthews, E.K. 1968: Alloxan on islet cell membrane potentials. British Journal of Pharmacology 34(3): 677P-678P
Ostenson, C.G. 1980: Alloxan reversibly impairs glucagon release and glucose oxidation by pancreatic A2-cells. Biochemical Journal 188(1): 201-206
Edström, C. 1971: Alloxan sensitivity of rats at various intervals following ligation of the pancreatic ducts. Acta Societatis Medicorum Upsaliensis 76(1-2): 77-86
Kojima, R.; Asano, H. 1972: Alloxan susceptibility and effects of diet in mice with congenital cataract. Igaku to Seibutsugaku. Medicine and Biology 84(1): 19-21
Davidson, P.M.; Young, D.G.; Logan, R.W.; Lockhart, S.; Patrick, W.J. 1984: Alloxan therapy for nesidioblastosis. Journal of Pediatric Surgery 19(1): 87-89
Malaisse, W.J. 1982: Alloxan toxicity to the pancreatic B-cell. a new hypothesis. Biochemical Pharmacology 31(22): 3527-3534
Ryle, P.R.; Barker, J.; Gaines, P.A.; Thomson, A.D.; Chakraborty, J. 1984: Alloxan-induced diabetes in the rat - protective action of (-) epicatechin?. Life Sciences 34(6): 591-595
Wexler, B.C. 1981: Alloxan-induced diabetes in young vs old Sprague-Dawley rats. Experimental Gerontology 16(1): 47-58
Ingebretsen, C.G.; Hawelu-Johnson, C.; Ingebretsen, W.R. 1983: Alloxan-induced diabetes reduces beta-adrenergic receptor number without affecting adenylate cyclase in rat ventricular membranes. Journal of Cardiovascular Pharmacology 5(3): 454-461
Asayama, K.; Nyfeler, F.; English, D.; Pilkis, S.J.; Burr, I.M. 1984: Alloxan-induced free radical production in isolated cells. Selective effect on islet cells. Diabetes 33(10): 1008-1011
Ruwart, M.J.; Sammons, D.W.; Kolaja, G.J.; Rush, B.D.; Friedle, N.M.; Adams, L.D. 1983: Alloxan-induced hyperglycemia in rats is reduced by 16,16-dimethyl-PGE2. Research Communications in Chemical Pathology and Pharmacology 40(2): 233-243
YoungLai, E.V. 1984: Alloxan-induced hyperglycemia increases progestin and androgen accumulation by isolated rabbit follicles in vitro. Experientia 40(3): 289-291
Hara, M.; Takahashi, K.; Yamaya, K.; Sasaki, H. 1983: Alloxan-induced insulin release from rat pancreas perfused in vitro. Horumon to Rinsho. Clinical Endocrinology 31(5): 427-432
Grankvist, K. 1981: Alloxan-induced luminol luminescence as a tool for investigating mechanisms of radical-mediated diabetogenicity. Biochemical Journal 200(3): 685-690
Inoue, Y. 1968: Alloxan-like action of some SH-inhibitors on glucose tolerance in rabbits. Endocrinologia Japonica 15(1): 1-7
Shokeir, A.A.; Elbagoury, S.M. 1966: Alloxan-schiff reagent for the detection of fixed rabies virus in the nerve cell. Journal of Medical Laboratory Technology 23(3): 191-193
Brown, I.H.; Miller, D.R. 1993: Alloy particle shape and sensitivity of high-copper amalgams to manipulative variables. American Journal of Dentistry 6(5): 248-254
Smerke, J. 1984: Alloy selection for crown and bridgework--a cheaper alternative?. Dental Technician 37(8): 12
Oilo, G. 1982: Alloys containing low concentration of precious metals. Tandlaegebladet 86(8): 273-275
Brockhurst, P.J.; Cannon, R.W. 1981: Alloys for crown and bridgework. Australian Dental Journal 26(5): 287-294
Ricci, H.P. 1971: Alloys for dental amalgam and of the sperical type. Acta Odontologica Venezolana 9(3): 205-212
Anonymous 1971: Alloys for dental amalgam containing fluoride. Council on Dental Materials and Devices. Journal of the American Dental Association 82(2): 399
José Guzmán, H. 1980: Alloys for dental castings. Revista de la Federacion Odontologica Colombiana 27(133): 51-63
Dobbs, H.S.; Robertson, J.L. 1982: Alloys for orthopaedic implant use. Engineering in Medicine 11(4): 175-182
Watson, P.A. 1982: Alloys for porcelain bonded to metal restorations. Ontario Dentist 59(1): 20-21
Anonymous 1980: Alloys of chrome cobalt for skeletons. Dental Press 16(1): 61-64
Leon, J. 1981: Alloys of non-precious metal. Quintessence of Dental Technology 5(8): 781-789
Oilo, G. 1982: Alloys with low content of precious metals. Tandlakartidningen 74(7): 370-372
Pierce, B.A.; Mitton, J.B. 1982: Allozyme heterozygosity and growth in the tiger salamander, Ambystoma tigrinum. Journal of Heredity 73(4): 250-253
Nygren, J. 1980: Allozyme variation in natural populations of field vole (Microtus agrestis L.). III. Survey of a cyclically density-varying population. Hereditas 93(1): 125-136
Faber, M.D.; Allport, G.; Freud, S. 1970: Allport's visit with Freud. Psychoanalytic Review 57(1): 60-64
Elms, A.C.; Allport GW; Freud S 1972: Allport, Freud, and the clean little boy. Psychoanalytic Review 59(4): 627-632
Benedetti, A.; Nardini, A.; Busonera, G. 1969: Allpurinol in the treatment of hyperuricemia and chronic gout. Revista Clinica Espanola 112(6): 141-154
Caplan, I.; Haynes, J.T. 1966: Allpyral and aqueous extracts in ragweed hayfever and asthma: a comparison. Journal of Asthma Research 4(2): 105-112
Zolov, B. 1968: Allpyral therapy. Systemic and local reactions--four-year study. Journal of the Maine Medical Association 59(6): 122-124
Goodman, M. 1982: Allrid v. Emory University: applying Georgia's medical malpractice statute of limitations in a difficult case. Journal of the Medical Association of Georgia 71(8): 573-575
Kaplan, N.M. 1980: Allupurinol and diuretic associated hyperuricaemia. Lancet 2(8201): 984
Barr, R.F.; McConaghy, N. 1972: Allusive thinking and its physiological correlates. Australian and New Zealand Journal of Psychiatry 6(2): 125-132
Bentall, H.H. 1968: Allwork SP: Fibrinolysis and bleeding in open-heart surgery. Lancet 1(7532): 4-8
Hargreaves, R. 1969: Ally of defeat. I. Practitioner 202(211): 713-718
Hargreaves, R. 1969: Ally of defeat. Ii. Practitioner 202(212): 853-856
Crane, G.W. 1981: Ally of the speech therapist--the dentist. Cal Magazine Certified Akers Laboratories 45(4): 20-24
Joglekar, G.V.; Balwani, J.H. 1967: Allyl alcohol induced hepatotoxicity in rats and its protection by Liv. 52. Journal of Experimental Medical Sciences 11(1): 7-9
Rando, R.R. 1974: Allyl alcohol-induced irreversible inhibition of yeast alcohol dehydrogenase. Biochemical Pharmacology 23(16): 2328-2331
Rabes, H.; Tuczek, H.V.; Brändle, H. 1968: Allyl formate poisoning in experimentally induced liver regeneration. Klinische Wochenschrift 46(8): 450-451
Pulverer, G. 1969: Allyl isothiocyanate: a new broad-spectrum antibiotic from nasturtium. German Medical Monthly 14(1): 27-30
Ioannou, Y.M.; Burka, L.T.; Matthews, H.B. 1984: Allyl isothiocyanate: comparative disposition in rats and mice. Toxicology and Applied Pharmacology 75(2): 173-181
Nelson, T.J.; Boor, P.J. 1982: Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues. Biochemical Pharmacology 31(4): 509-514
Boor, P.J.; Nelson, T.J.; Chieco, P. 1980: Allylamine cardiotoxicity: II. Histopathology and histochemistry. American Journal of Pathology 100(3): 739-764
Boor, P.J. 1983: Allylamine cardiotoxicity: metabolism and mechanism. Advances in Experimental Medicine and Biology 161: 533-541
Cortés-Prieto, J.; Bosch, A.O.; Rocha, J.A. 1980: Allylestrenol: three years of experience with Gestanon in threatened abortion and premature labor. Clinical Therapeutics 3(3): 200-208
Hoffmann, H.M.; Janes, N.F. 1969: Allylfurans. Journal of the Chemical Society. Perkin Transactions 1 10: 1456-1458
Ortiz, J.G.; Giacobini, E.; Schmidt-Glenewinkel, T. 1983: Allylglycine affects acetylation of putrescine and spermidine in mouse brain. Neuropharmacology 22(10): 1237-1239
Balcar, V.J.; Johnston, G.A. 1974: Allylglycine, and inhibitor of the uptake of L-leucine and L-proline in rat brain slices. Biochemical Pharmacology 23(4): 821-827
Oesterling, T.O.; Gustafson, J.H. 1970: Allylic phosphate hydrolysis. Kinetics and mechanism of degradation of 3-beta,17-alpha-dihydroxy-6-alpha-methylpregn-4-en-20-one 17-acetate, 3-phosphate. Journal of Pharmaceutical Sciences 59(11): 1612-1616
Frihart, C.R.; Leonard, N.J. 1973: Allylic rearrangement from O6 to C-8 in the guanine series. Journal of the American Chemical Society 95(21): 7174-7175
Bhaté, P.; Horton, D.; Priebe, W. 1985: Allylic rearrangement of 6-deoxyglycals having practical utility. Carbohydrate Research 144(2): 331-337
Pinelli, A.; Favalli, L. 1973: Allylisopropylacetamide-induced propyria-protective effect of 3,5-dimethylisooxazole. Biochemical Pharmacology 22(7): 797-801
Portoghese, P.S.; Alreja, B.D.; Larson, D.L. 1981: Allylprodine analogues as receptor probes. Evidence that phenolic and nonphenolic ligands interact with different subsites on identical opioid receptors. Journal of Medicinal Chemistry 24(7): 782-787
Biermann, J. 1972: Allylthiocarbamide injections into the esophageal wall with cicatrix stricture. Das Deutsche Gesundheitswesen 27(38): 1819-1820
Sweeney, H.T. 1981: Alma C. Leech is 1981 recipient of DSSNY Distinguished Service Award. New York State Dental Journal 47(2): 85-86
Wands, D.H. 1968: Almanac Dentistry. Bulletin of the History of Dentistry 16(1): 10-40
Baker, R.M.; Haynes, R.H. 1972: UV-induced recombination and repair of parental lambda bacteriophages labeled by means of host-controlled modification. Virology 50(1): 11-26
Stanley, N.N. 1981: Almitrine a promising new drug for sleep hypoxia. Lancet 2(8255): 1105-1106
Krieger, J.; Mangin, P.; Kurtz, D. 1982: Almitrine and sleep apnea. Lancet 2(8291): 210
Howard, P. 1984: Almitrine bismesylate (Vectarion). Bulletin Europeen de Physiopathologie Respiratoire 20(2): 99-103
Fleming, P.J.; Levine, M.R.; Lewis, G.T.; Pauly, N. 1983: Almitrine bismesylate in congenital central hypoventilation. European Journal of Respiratory Diseases. Suppl 126: 307-312
González Ruiz, J.M.; Villamor León, J.; García-Satué, J.L.; Sánchez Agudo, L.; Calatrava, J.M.; Carreras, J. 1994: Almitrine bismesylate treatment in chronic respiratory insufficiency. Revista Clinica Espanola 194(12): 1007-1012
Labrid, C.; Regnier, G.; Laubie, M. 1983: Almitrine bismesylate: pharmacological review and structure-activity relationships. European Journal of Respiratory Diseases. Supplement 126: 185-189
Tellier, P.; Voisin, C. 1984: Almitrine dimesylate: deductions and therapeutic prospects. Presse Medicale 13(34): 2099-2103
Korbut, R.; Byrska-Danek, A.; Gryglewski, R.J. 1982: Almitrine increases plasma fibrinolytic activity through the release of prostacyclin from lungs into circulation. Pharmacological Research Communications 14(10): 959-965
Seignalet, C.; Préfaut, C.; Gonzales, C.; Michel, F.B. 1980: Almitrine per os in the therapy of chronic obstructive bronchopneumopathies. Revue Francaise des Maladies Respiratoires 8(6): 627-633
Gryglewski, R.J. 1980: Almitrine, a powerful liberator of prostacyclin in vivo. Revue Francaise des Maladies Respiratoires 8(6): 617-620
Takasaki, S. 1984: Almond alpha-L-fucosidases. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 29(6): 483-485
Takahashi, N. 1984: Almond glycopeptidase. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 29(2): 134-137
Takahashi, T.; Nishibe, H. 1981: Almond glycopeptidase acting on aspartylglycosylamine linkages. Multiplicity and substrate specificity. Biochimica et Biophysica Acta 657(2): 457-467
Waldman, H.B. 1995: Almost four million children with disabilities. Asdc Journal of Dentistry for Children 62(3): 205-209
Juckett, G. 1994: Almost heaven?: rural family practice in West Virginia. West Virginia Medical Journal 90(11): 462-463
Davault, G. 1995: Almost misdiagnosed: utilization of Romhilt-Estes electrocardiographic criteria for left ventricular hypertrophy. Journal of the American Academy of Nurse Practitioners 7(9): 435-439
Matsunaga, E. 1982: Almost synchronous appearance of bilateral retinoblastomas. American Journal of Medical Genetics 11(4): 485-487
Aoustin, J.; Abdalahoui, A. 1968: Almost total traumatic avulsion of the skin of the male genital organs. Memoires. Academie de Chirurgie 94(12): 385-386
Kerson, T.S. 1981: Almshouse to municipal hospital: the Baltimore experience. Bulletin of the History of Medicine 55(2): 203-220
Melich, H. 1966: Alnagon. Ceskoslovenska Farmacie 15(1): 61-62
Anonymous 1968: Aloalbuminemia. Revista Clinica Espanola 111(5): 552-553
Gaba, A.R.; Anderson, G.J.; VanDyke, D.L.; Chason, J.L. 1982: Alobar holoprosencephaly and otocephaly in a female infant with a normal karyotype and placental villitis. Journal of Medical Genetics 19(1): 78
Filly, R.A.; Chinn, D.H.; Callen, P.W. 1984: Alobar holoprosencephaly: ultrasonographic prenatal diagnosis. Radiology 151(2): 455-459
Kotte, W.; Kunze, P. 1971: Alobar holoprosenencephaly (arhinencephaly) with median lip-palate cleft and normal karyotyping. Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 114(2): 173-184
Aldor, E.; Heeger, H. 1967: Alodan compositum premedication in cardiac and blood circulation diagnostics. Wiener Medizinische Wochenschrift 117(32): 745-746
Felts, J.H. 1983: Aloe Vera, true and false. North Carolina Medical Journal 44(9): 599
Davis, R.H.; DiDonato, J.J.; Johnson, R.W.; Stewart, C.B. 1994: Aloe vera, hydrocortisone, and sterol influence on wound tensile strength and anti-inflammation. Journal of the American Podiatric Medical Association 84(12): 614-621
Lutomski, J. 1984: Aloe, a succulent plant with therapeutic action. Pharmazie in Unserer Zeit 13(6): 172-176
Nikolaev, A.B. 1966: Aloe--a valuable medicinal plant. Fel'dsher i Akusherka 31(4): 51-53
Foucaud, A.; Réveillère, H.; Mahé, M. 1968: Aloes-wood, agalloch-wood, eagle-wood. La Presse Medicale 76(21): 1028-1029
Hutchins, N. 1966: Aloha from Hawaii. Journal of Practical Nursing 16(2): 21 Passim
Marks, R.; Skinsnes, O.K.; de Veuster, D. 1973: Aloha oe, Father Damien de Veuster. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 41(2): 215-219
Alzheimer, A. 1969: Alois Alzheimer (1864-1915). Neurohistopathologist. JAMA 208(6): 1017-1018
Sagarra, S.; Kornmüller, A.E. 1970: Alois E. Kornmüller. Archivos de Neurobiologia 33(4): 463-465
Janzen, R.; Kornmüller, A.E. 1969: Alois E. Kornmüller 1905-1968. Deutsche Zeitschrift für Nervenheilkunde 195(3): 157-160
Snyder, C.; Zirm, E.K. 1965: Alois Glogar, Karl Bräuer, and Eduard Konrad Zirm. Archives of Ophthalmology 74(6): 871-874
Piper, H.F.; Meesmann, A. 1969: Alois Meesmann. Medizinische Klinik 64(48): 2271-2272
Anonymous 1969: Alone in the city. South African Medical Journal 43(16): 458
Plattner, A.; Schmid, M. 1995: Alone on the ward. Osterreichische Krankenpflegezeitschrift 48(4): 17-19
Schafer, R. 1995: Aloneness in the countertransference. Psychoanalytic Quarterly 64(3): 496-516
Skolnick, A.A. 1995: Along US southern border, pollution, poverty, ignorance, and greed threaten nation's health. JAMA 273(19): 1478; 1480-1482
Lenin, V.I. 1970: Along the path indicated by V.I. Lenin. Farmakologiia i Toksikologiia 33(2): 131-133
Malyshev, N.I.; Markov, I.; Rudova, G. 1969: Along the path of research (from the work experience of a veterinary section). Veterinariia 46(4): 12-14
Kler, J.H.; van Leeuwenhoek, A.; Silvius, F. 1983: Along the path to modern medicine. Journal of the Medical Society of new Jersey 80(7): 552
Senseman, L.A. 1972: Along the road to Vellore. Rhode Island Medical Journal 55(5): 156-157 Passim
Kovanov, V.V. 1980: Along the roads of war. Voenno-Meditsinskii Zhurnal 5: 69-73
Cobb, W.M.; Smith, A.G. 1969: Alonzo de Grate Smith, M.S., M.D., 1890-. Journal of the National Medical Association 61(4): 358-360
Jackson, F.; Tomkin, G.H. 1981: Alopecia Universalis - Is pituitary function abnormal?. Irish Medical Journal 74(11): 328-329
Feil, V.J.; Lamoureux, C.H. 1974: Alopecia activity of cyclophosphamide metabolites and related compounds in sheep. Cancer Research 34(10): 2596-2598
Kudejko, J.; Polańska, B. 1980: Alopecia after hair washing with Ixi powder. Przeglad Dermatologiczny 67(2): 209-213
Welch, D.; Lewis, K. 1980: Alopecia and chemotherapy. American Journal of Nursing 80(5): 903-905
Calvert, W. 1966: Alopecia and cytotoxic drugs. British Medical Journal 2(5517): 831
Harms, M. 1980: Alopecia and hair changes following colchicine therapy. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(3): 161-163
Auerbach, R. 1968: Alopecia and ichthyosis. Archives of Dermatology 98(6): 682
Auerbach, R.; Orentrich, N. 1968: Alopecia and ichthyosis secondary to allopurinol. Archives of Dermatology 98(1): 104
Prenosil, J. 1981: Alopecia and immunotherapy using 2,4-dinitrochlorobenzene. Ceskoslovenska Dermatologie 56(5): 307-311
Marshall, A.; Williams, M.J. 1971: Alopecia and levodopa. British Medical Journal 2(5752): 47
Williams, M.L.; Packman, S.; Cowan, M.J. 1983: Alopecia and periorificial dermatitis in biotin-responsive multiple carboxylase deficiency. Journal of the American Academy of Dermatology 9(1): 97-103
Erichsen, B.; Erichsen, H. 1982: Alopecia and surgery. Ugeskrift for Laeger 144(8): 548-550
Gilhar, A.; Haim, S.; Benderly, A. 1983: Alopecia and vitamins. Harefuah 104(3): 110-111
Wüstner, H.; Orfanos, C.E. 1974: Alopecia androgenetica and its local treatment with estrogen- and corticosteroid externa. Zeitschrift für Hautkrankheiten 49(20): 879-888
Andersen, P.T. 1984: Alopecia areata after epidural morphine. Anesthesia and Analgesia 63(12): 1142
Toyka, K.V.; Förster, C.; Dorn, M. 1974: Alopecia areata and EEG-changes. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 25(11): 558-560
Penders, A.J. 1968: Alopecia areata and atopy. Dermatologica 136(5): 395-399
Summerly, R.; Watson, D.M.; Monckton, P.W. 1966: Alopecia areata and cataract. Archives of Dermatology 93(4): 411-412
Salamon, T.; Musafija, A.; Milicević, M. 1971: Alopecia areata and diseases of the thyroid gland. Dermatologica 142(1): 62-63
Roedig, E.; Hahn, G. 1982: Alopecia areata and its supportive treatment possibility with Plenosol. Zfa. Zeitschrift für Allgemeinmedizin 58(23): 1252-1254
Du Vivier, A.; Munro, D.D. 1974: Alopecia areata and mongolism. Proceedings of the Royal Society of Medicine 67(7): 596-597
Skinner, R.B.; Light, W.H.; Bale, G.F.; Rosenberg, E.W.; Leonardi, C. 1995: Alopecia areata and presence of cytomegalovirus DNA. JAMA 273(18): 1419-1420
Medvedev, V.N. 1964: Alopecia areata as a rare complication of chronic tonsillitis. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 24(4): 73-74
Barduagni, O.; Nini, G. 1969: Alopecia areata associated with craniofacial dysostosis (Crouzon). Giornale Italiano di Dermatolotia. Minerva Dermatologica 44(10): 521-524
Breuninger, H.; Feine, U. 1968: Alopecia areata caused by embolic deportation of a grain of radiogold following insertion into the neck region. Zeitschrift für Laryngologie Rhinologie Otologie und ihre Grenzgebiete 47(6): 469-471
Jackson, D.; Church, R.E.; Ebling, F.J. 1971: Alopecia areata hairs: a scanning electron microscope study. British Journal of Dermatology 85(3): 242-246
Frankel, E.B. 1984: Alopecia areata in an area of hair transplantation. Archives of Dermatology 120(4): 435
Izumi, A.K.; Rosato, F.E.; Shelley, W.B. 1970: Alopecia areata in association with intestinal polyposis. The relationship of two syndromes--Gardner's and Cronkhite--Canada. Acta Dermato-Venereologica 50(5): 381-384
Steigleder, G.K. 1980: Alopecia areata in diabetes. Deutsche Medizinische Wochenschrift 105(20): 714
Mehlman, R.D.; Griesemer, R.D. 1968: Alopecia areata in the very young. American Journal of Psychiatry 125(5): 605-614
Rogalla, G.; Bourlond, A. 1974: Alopecia areata of the vertex in children. Archives Belges de Dermatologie 30(4): 285-288
Rhodes, E.L.; Dolman, W.; Kennedy, C.; Taylor, R.R. 1981: Alopecia areata regrowth induced by Primula obconica. British Journal of Dermatology 104(3): 339-340
Tonkin, N.; Popov, A.; Popkhristova, E. 1981: Alopecia areata studied by fluorescence and immunofluorescence microscopy methods. Vestnik Dermatologii i Venerologii 2: 16-18
Fenton, D.A.; Wilkinson, J.D. 1982: Alopecia areata treated with tropical minoxidil. Journal of the Royal Society of Medicine 75(12): 963-965
Duchková, H.; Horáková, E.; Kulenda, Z. 1971: Alopecia areata, its therapy and results of some biochemical tests. Ceskoslovenska Dermatologie 46(5): 203-208
Cunliffe, W.J.; Hall, R.; Stevenson, C.J.; Weightman, D. 1969: Alopecia areata, thyroid disease and autoimmunity. British Journal of Dermatology 81(12): 877-881
Thompson, D.M.; Robinson, T.W.; Lennard-Jones, J. 1974: Alopecia areata, vitiligo, scleroderma and ulcerative colitis. Proceedings of the Royal Society of Medicine 67(10): 1010-1012
Jautová, J.; Jarcusková, D.; Ficová, M.; Dubivská, M. 1995: Alopecia areata--an autoimmune disorder?. Bratislavske Lekarske Listy 96(3): 144-147
Gip, L.; Lodin, A.; Molin, L. 1969: Alopecia areata. a follow-up investigation of outpatient material. Acta Dermato-Venereologica 49(2): 180-188
Kern, F.; Hoffman, W.H.; Hambrick, G.W.; Blizzard, R.M. 1973: Alopecia areata. Immunologic studies and treatment with prednisone. Archives of Dermatology 107(3): 407-412
Betterle, C.; Cipriani, R.; Pedini, B.; Peserico, A. 1984: Alopecia areata: a heterogeneous disease?. Lancet 2(8403): 635
Gadisseux, J.F.; Fournaux, J.; Hallet, J.; Ferriere, G. 1983: Sultopride, treatment of choice for agitation in severe encephalopathies. Apropos of 33 cases in a neuropediatric milieu. Neuropsychiatrie de l'Enfance et de l'Adolescence 31(2-3): 159-164
Messenger, A.G.; Bleehen, S.S. 1984: Alopecia areata: light and electron microscopic pathology of the regrowing white hair. British Journal of Dermatology 110(2): 155-162
Mitchell, A.J.; Krull, E.A. 1984: Alopecia areata: pathogenesis and treatment. Journal of the American Academy of Dermatology 11(5 Part 1): 763-775
Spanopoulos, G.J. 1967: Alopecia as a complication of gout. Practitioner 198(185): 426-427
Leaker, B.; Whitworth, J.A. 1984: Alopecia associated with captopril treatment. Australian and New Zealand Journal of Medicine 14(6): 866
Estrella, R.R.; Azulay, R.D.; Peixoto, P.R.; Marinho, D.E. 1970: Alopecia caused by thallium sulfate. Anais Brasileiros de Dermatologia 45(4): 333-338
Herrmann, W.P. 1969: Alopecia circumscripta. Zeitschrift für Allgemeinmedizin 45(12): 548-553
Green, A.; Hosking, G.P. 1980: Alopecia in association with a carboxylation defect. Journal of Inherited Metabolic Disease 3(4): 163
Farkas, L. 1966: Alopecia in childhood. Archiv für Klinische und Experimentelle Dermatologie 227(1): 530-535
De Clercq, E.; Descamps, J.; De Somer, P.; Samyn, C.; Smets, G. 1980: Alopecia in laboratory animals induced by a polyampholyte, polyethylene alanine. Experientia 36(9): 1107-1108
Beurey, J.; Jeandidier, P. 1971: Alopecia in pregnancy. Revue Francaise de Gynecologie et d'Obstetrique 66(10): 595-598
Beare-Rogers, J.L.; McGowan, J.E. 1973: Alopecia in rats housed in groups. Laboratory Animals 7(3): 237-238
Söltz-Szöts, J. 1968: Alopecia in the female. Wiener Medizinische Wochenschrift 118(1): 18-19
Sterry, W.; Konrads, A.; Nase, J. 1980: Alopecia in thyroid diseases: characteristic trichograms. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(6): 308-314
Rook, A. 1971: Alopecia in young women. Nursing Mirror and Midwives Journal 133(21): 18-20
Pinetti, P.; Biggio, P. 1968: Alopecia inducing action of cantharides in humans. Bollettino della Societa Italiana di Biologia Sperimentale 44(7): 675-676
Hommes, O.R.; Prick, J.J. 1966: Alopecia maligna elucidated from the psychosomatic viewpoint. Nederlands Tijdschrift Voor Geneeskunde 110(4): 168-174
Chernosky, M.E. 1970: Alopecia mucinosa. Archives of Dermatology 102(3): 343-344
Felman, Y.M.; Shapiro, L.; Moser, H.S. 1969: Alopecia mucinosa and malignant lymphoma. Report of a case with autopsy. Dermatologica 138(6): 444-452
Kubicz, J. 1973: Alopecia mucinosa in the course of psoriasis vulgaris. Przeglad Dermatologiczny 60(6): 769-771
Burket, J.M. 1974: Alopecia mucinosa with neurofollicular changes. Archives of Dermatology 110(2): 243-244
Coskey, R.J.; Mehregan, A.H. 1970: Alopecia mucinosa. a follow-up study. Archives of Dermatology 102(2): 193-194
Pinkus, H. 1983: Alopecia mucinosa. Additional data in 1983. Archives of Dermatology 119(8): 698-699
Snyder, R.A.; Crain, W.R.; McNutt, N.S. 1984: Alopecia mucinosa. Report of a case with diffuse alopecia and normal-appearing scalp skin. Archives of Dermatology 120(4): 496-498
Schorr, W.F.; Swanson, P.M.; Gomez, F.; Reyes, C.N. 1970: Alopecia neoplastica. Hair loss resembling alopecia areata caused by metastatic breast cancer. JAMA 213(8): 1335-1337
Manders, E.K.; Graham, W.P. 1984: Alopecia reduction by scalp expansion. Journal of Dermatologic Surgery and Oncology 10(12): 967-969
Kobori, T. 1966: Alopecia relating to internal diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 24(2): 224-227
Koblenzer, P.J.; Weiner, L.B. 1969: Alopecia secondary to thallium intoxication. Archives of Dermatology 99(6): 777
Martin, J.; Ross, J.B. 1983: Alopecia totalis as a presentation of cutaneous metastasis (alopecia neoplastica). International Journal of Dermatology 22(8): 487-489
Cole, G.W.; Herzlinger, D. 1984: Alopecia universalis in identical twins. International Journal of Dermatology 23(4): 283
Wheeler, G.E.; Barrows, G.H. 1981: Alopecia universalis. a manifestation of occult amyloidosis and multiple myeloma. Archives of Dermatology 117(12): 815-816
Munnich, A.; Saudubray, J.M.; Ogier, H.; Marsac, C.; Charpentier, C.; Frezal, J. 1980: Alopecia, chronic candidodis, mental retardation and repeated ketoacidosic comas curable by biotin administration: multiple carboxylases deficiency. Annales de Medecine Interne 131(7): 435-437
Brehm, G. 1966: Alopecia, dysgammaglobulinemia and mandibulofacial dysostosis (Franceschetti-Zwahlen disease). Asthetische Medizin 15(7): 226-229
Pinkus, H. 1980: Alopecia. Clinicopathologic correlations. International Journal of Dermatology 19(5): 245-253
Jillson, O.F. 1983: Alopecia. I. Alopecia areata. Cutis 31(3): 262; 266 269-273
Jillson, O.F. 1983: Alopecia. II. Trichotillomania (trichotillohabitus). Cutis 31(4): 383; 386, 389
Jillson, O.F. 1983: Alopecia. III. Diffuse hair loss (nonscarring). Cutis 31(5): 465; 469 472 Passim
Ioannides, G. 1982: Alopecia: a pathologist's view. International Journal of Dermatology 21(6): 316-328
Jadassohn, W. 1966: Alopecia: additional report on therapy. Archiv für Klinische und Experimentelle Dermatologie 227(1): 498-504
Cohen, M.; Shafir, R. 1995: Alopecia: an unfavorable result of using a skin-stretching device. Plastic and Reconstructive Surgery 96(3): 747-748
Nielson, T.A.; Reichel, M. 1995: Alopecia: diagnosis and management. American Family Physician 51(6): 1513-1522; 1527-1528
Baxley, K.O.; Erdman, L.K.; Henry, E.B.; Roof, B.J. 1984: Alopecia: effect on cancer patients' body image. Cancer Nursing 7(6): 499-503
Muller, S.A. 1973: Alopecia: syndromes of genetic significance. Journal of Investigative Dermatology 60(6): 475-492
Weigand, D.A. 1968: Alopecias--diagnostic and pathogenetic considerations. South Dakota Journal of Medicine 21(7): 131-141
Weigand, D.A. 1968: Alopecias--diagnostic and pathogenic considerations. Journal of the Oklahoma State Medical Association 61(6): 253-264
Harth, E.; Tzanakou, E. 1974: Alopex: a stochastic method for determining visual receptive fields. Vision Research 14(12): 1475-1482
Serson, D.; Barbosa, J.E.; Cardoso, O.M. 1972: Aloplastic implants in dentistry. Anuario Brasileiro de Odontologia 1: 97-104
Goldemberg, A.L.; Farias, R.N.; Trucco, R.E. 1973: Alosteric transitions and membrane-bound ATPase from rat tissues: the effect of fat deprivation on the allosteric inhibition by fluoride. Biochimica et Biophysica Acta 291(2): 489-493
Greth, F.; Pissarro, B.; Duché, D.J. 1970: Alouette's test: comparison with other tests. Limitations in the detection of dyslexic children. Revue de Neuropsychiatrie Infantile et d'Hygiene Mentale de l'Enfance 1970(Suppl): 69-72
Wissing, E.G.; Ansprenger, A.G. 1973: Aloys George Ansprenger, M.D. 1905-1972. Radiology 109(2): 487
Théodoridès, J.; Vetter, T.; Vetter, A.R. 1966: Aloys Rudolph Vetter (1765-1806) and human helminthology. Biologie Medicale 55(3): 219-226
Galvani, A.L. 1967: Aloysio Luigi Galvani (1737-1798) discoverer of animal electricity. JAMA 201(8): 626-627
Alper, C.A.; Rosen, F.S. 1967: Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. Journal of Clinical Investigation 46(12): 2021-2034
Alper, M. 1969: Alper to establish graduate program. Explorer: the Journal of the School of Dentistry of the University of Missouri at Kansas City. University of Missouri at Kansas City. School of Dentistry 32(1): 13
von der Linde, J.; Walter, L. 1984: Alpers syndrome (a case report). Padiatrie und Grenzgebiete 23(4): 225-241
Crompton, M.R. 1968: Alpers' disease -- a variant of Creutzfeldt-Jakob disease and subacute spongiform encephalopathy?. Acta Neuropathologica 10(2): 99-104
Kochibe, N. 1984: Alpha #1----2 fucosidase of Bacillus fulminans. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 29(6): 480-482
Labadie, P. 1973: Alpha 1 - antitrypsin, a modern glycoprotein. La Revue du Praticien 23(31): 2876 Passim
Paxton, J.W. 1983: Alpha 1 -acid glycoprotein and binding of basic drugs. Methods and Findings in Experimental and Clinical Pharmacology 5(9): 635-648
Gordon, H.W.; Dixon, J.; Rogers, J.C.; Mittman, C.; Lieberman, J. 1972: Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency. Human Pathology 3(3): 361-370
Creason, P.L.; Creason, M.T. 1972: Alpha 1 -antitrypsin Pi types by crossed-electrophoresis. American Journal of Medical Technology 38(8): 292-297
Lieberman, J. 1971: Alpha 1 -antitrypsin and pepsin inhibition. New England Journal of Medicine 285(9): 524-525
Lieberman, J. 1973: Alpha 1 -antitrypsin deficiency. Medical Clinics of North America 57(3): 691-706
Mittman, C.; Barbela, T.; Lieberman, J. 1973: Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 33-38
Glauser, M.P. 1971: Alpha 1 -antitrypsin deficiency associated with pulmonary emphysema. a study of the clinical character of patients. Schweizerische Medizinische Wochenschrift 101(27): 999-1003
Creason, M.T.; Creason, P.L. 1972: Alpha 1 -antitrypsin immunoelectrophoresis. American Journal of Medical Technology 38(10): 387-393
Schumacher, G.F. 1970: Alpha 1 -antitrypsin in genital secretions. Journal of Reproductive Medicine 5(1): 3-9
Kueppers, F. 1972: Alpha 1 -antitrypsin levels and electrophoretic patterns of several deficient phenotypes. Humangenetik 15(1): 1-6
Montplaisir, S.; Rabin, B.; Pelletier, M.; Rose, N.R.; Alpert, E. 1973: Alpha 1 -fetoprotein content of gastric carcinoma and hepatic metastases. American Journal of Digestive Diseases 18(5): 416-418
Zizkovský, V.; Kordac, V.; Obrovská, D.; Masopust, J. 1972: Alpha 1 -fetoprotein in carcinoid. New England Journal of Medicine 287(21): 1102-1103
Munoz, J.R.; Guillen, G.; Toribio, F.P. 1972: Alpha 1 -fetoprotein in hepatomas, neoplasms, and other ilnesses. Lancet 1(7755): 850-851
Lehmann, F.G.; Lehmann, D.; Martini, G.A. 1971: Alpha 1 -foetoprotein. Isolation and crystallization from human plasma. Clinica Chimica Acta; International Journal of Clinical Chemistry 33(1): 197-206
Meucci, O.; Scorziello, A.; Avallone, A.; Florio, T.; D'Alto, V.; Fattore, M.; Schettini, G. 1995: Alpha 1 B, but not alpha 1A, adrenoreceptor activates calcium influx through the stimulation of a tyrosine kinase/phosphotyrosine phosphatase pathway, following noradrenaline-induced emptying of IP3 sensitive calcium stores, in PC Cl3 rat thyroid cell line. Biochemical and Biophysical Research Communications 209(2): 630-638
Battaglia, G.; Shannon, M.; Borgundvaag, B.; Titeler, M. 1984: Alpha 1 adrenergic receptors in the porcine pituitary neurointermediate lobe: detection with [3H]ketanserin. Journal of Receptor Research 4(7): 713-726
Vermylen, J.; Fiocchi, R.; Fagard, R.; Lijnen, P.; Staessen, J.; Amery, A. 1983: Alpha 1 antagonistic and antiserotoninergic action during administration of ketanserin. British Medical Journal 287(6404): 1551-1552
Boyd, J.E.; Collings, P.; Crofton, P.M.; Blundell, G.; Davis, J.M. 1984: Alpha 1 antitrypsin and lung function in British coalminers. British Journal of Industrial Medicine 41(4): 455-458
Ward, A.M.; Underwood, J.C. 1973: Alpha 1 antitrypsin deficiency and liver disease in childhood. Journal of Pathology 109(1)
McLeod, J. 1982: Alpha 1 antitrypsin deficiency and lung function. New Zealand Medical Journal 95(700): 59
Allende, H.D.; Ona, F.V. 1982: Alpha 1 antitrypsin deficiency and plasma thromboplastin antecedent deficiency--a new association?. American Journal of the Medical Sciences 284(2): 42-46
Jones, M.C.; Thomas, G.O. 1971: Alpha antitrypsin deficiency and pulmonary emphysema. Thorax 26(6): 652-662
Lebeau, B.; Rochemaure, J. 1973: Alpha 1 antitrypsin deficiency during chronic bronchopneumopathies. La Nouvelle Presse Medicale 2(13): 843-848
Houstek, J.; Copová, M.; Zapletal, A.; Tomásová, H.; Samánek, M. 1973: Alpha 1 antitrypsin deficiency in a child with chronic lung disease. Chest 64(6): 773-776
Rodríguez Cuartero, A.; Núñez Carril, J. 1974: Alpha 1 antitrypsin deficiency in an adult with pulmonary emphysema and hepatic cirrhosis. Revista Clinica Espanola 133(3): 267-272
Glasgow, J.F.; Lynch, M.J.; Hercz, A.; Levison, H.; Sass-Kortsak, A. 1973: Alpha 1 antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. American Journal of Medicine 54(2): 181-194
Mehta, C.D.; Panthaki, M.H.; Banker, D.D. 1983: Alpha 1 antitrypsin deficiency in chronic obstructive pulmonary disease (COPD). Indian Journal of Pathology and Microbiology 26(3): 161-164
Hutchison, D.C.; Tobin, M.J.; Cook, P.J. 1983: Alpha 1 antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association. British Journal of Diseases of the Chest 77(1): 28-34
Tobin, M.J.; Cook, P.J.; Hutchison, D.C. 1983: Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. British Journal of Diseases of the Chest 77(1): 14-27
Horton, F.O.; Mackenthun, A.V.; Anderson, P.S.; Patterson, C.D.; Hammarsten, J.F. 1980: Alpha 1 antitrypsin heterozygotes (Pi type MZ). a longitudinal study of the risk of development of chronic air flow limitation. Chest 77(2 Suppl): 261-264
Vidal, J.; Robinet-Levy, M.; Michel, F.B. 1972: Alpha 1 antitrypsin homozygous deficiency associated with chronic respiratory diseases. Report of 7 cases observed among 600 subjects examined. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 48(50): 3291-3297
Hanzlick, J.; Bosseckert, H.; Kröhne, H.J.; Koch, W.; Herrmann, H.; Kunze, M.; Seidel, K. 1973: Alpha 1 antitrypsin in rheumatic diseases. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(14): 430-437
Young, R.C.; Headings, V.E.; Bose, S.; Harden, K.A.; Crockett, E.D.; Hackney, R.L. 1973: Alpha 1 antitrypsin levels in sarcoidosis: relationship to disease activity. Chest 64(1): 39-45
Qizilbash, A.; Young-Pong, O. 1983: Alpha 1 antitrypsin liver disease differential diagnosis of PAS-positive, diastase-resistant globules in liver cells. American Journal of Clinical Pathology 79(6): 697-702
Lieberman, J.; Mittman, C.; Gordon, H.W. 1972: Alpha 1 antitrypsinin the livers of patients with emphysema. Science 175(4017): 63-65
De Benedetti, F.; Piombo, I. 1974: Alpha 1 fetal proteins in chronic hepatitis. Minerva Gastroenterologica 20(2): 76
Mukojima, T.; Hattori, N. 1971: Alpha 1 fetoglobulin and hepatoma. Gan no Rinsho. Japan Journal of Cancer Clinics 17(6): 419-423
Daiber, A.; Carmona, A.; Soerensen, R. 1971: Alpha 1 fetoglobulin in hapatoma. Revista Medica de Chile 99(9): 634-637
Florin-Christensen, A.; Arana, R.M. 1973: Alpha 1 fetoprotein and antialpha 1 fetoprotein in acute viral hepatitis. British Medical Journal 2(5858): 94-95
Viot, M.; Thyss, A.; Schneider, M.; Viot, G.; Ramaioli, A.; Cambon, P.; Lalanne, C.M. 1983: Alpha 1 isoenzyme of alkaline phosphatases. Clinical importance and value for the detection of liver metastases. Cancer 52(1): 140-145
Rimm, D.L.; Koslov, E.R.; Kebriaei, P.; Cianci, C.D.; Morrow, J.S. 1995: Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proceedings of the National Academy of Sciences of the United States of America 92(19): 8813-8817
McCaughran, J.A.; Edwards, E.; Schechter, N.; Friedman, R. 1984: Alpha 1- and alpha 2-adrenoceptor binding in the Dahl rat model of hypertension. Brain Research Bulletin 12(6): 697-702
Roquebert, J.; Malek, A.; Creuzet, M.H.; Cognie, F.; Pontagnier, H. 1983: Alpha 1- and alpha 2-adrenoceptor selectivity of moxisylyte (thymoxamine) and its metabolites in the pithed rat. Archives Internationales de Pharmacodynamie et de Therapie 266(2): 282-293
Godfraind, T.; Miller, R.C. 1982: Alpha 1- and alpha 2-adrenoceptor stimulation and Ca fluxes in isolated rat aorta. Archives Internationales de Pharmacodynamie et de Therapie 256(1): 171-172
Heusch, G.; Deussen, A.; Schipke, J.; Thämer, V. 1984: Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. Journal of Cardiovascular Pharmacology 6(5): 961-968
Dausse, J.P.; Le Quan-Bui, K.H.; Meyer, P. 1982: Alpha 1- and alpha 2-adrenoceptors in rat cerebral cortex: effects of neonatal treatment with 6-hydroxydopamine. European Journal of Pharmacology 78(1): 15-20
Ueda, S.; Satake, N.; Shibata, S. 1984: Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of isolated rabbit urinary bladder and urethra. European Journal of Pharmacology 103(3-4): 249-254
Starke, K.; Docherty, J.R. 1981: Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications. Journal of Cardiovascular Pharmacology 3(Suppl 1): S14-S23
Giussani, D.A.; Moore, P.J.; Bennet, L.; Spencer, J.A.; Hanson, M.A. 1995: Alpha 1- and alpha 2-adrenoreceptor actions of phentolamine and prazosin on breathing movements in fetal sheep in utero. Journal of Physiology 486: 249-255
Sobolev, V.I.; Dingamtar, N. 1982: Alpha 1- and beta 1-adrenergic reactions in acclimatization to cold. Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova 68(1): 34-38
Meier, K.E.; Sternfeld, D.R.; Insel, P.A. 1984: Alpha 1- and beta 2-adrenergic receptors co-expressed on cloned MDCK cells are distinct glycoproteins. Biochemical and Biophysical Research Communications 118(1): 73-81
Ishibe, T.; Kuno, T.; Tanaka, C. 1984: Alpha 1- and beta-adrenergic and muscarinic cholinergic receptors in guinea-pig nasal mucosa. European Journal of Pharmacology 106(1): 107-112
Pacuszka, T.; Kościelak, J. 1974: Alpha 1--greater than 2 fucosyltransferase of human bone marrow. Febs Letters 41(2): 348-351
Blackmore, P.F.; Exton, J.H. 1981: Alpha 1-Adrenergic stimulation of Ca2+ mobilization without phosphorylase activation in hepatocytes from phosphorylase b kinase-deficient gsd/gsd rats. Biochemical Journal 198(2): 379-383
Morganti, A.; Sala, C.; Palermo, A.; Turolo, L.; Zanchetti, A. 1981: Alpha 1-Adrenoceptor blockade: dissociation of its effects on renin release and arterial blood pressure in man. Clinical Science 61 Suppl. 7: 307s-309s
Van Dijk, W.; Havenaar, E.C.; Brinkman-van der Linden, E.C. 1995: Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconjugate Journal 12(3): 227-233
Denson, D.; Coyle, D.; Thompson, G.; Myers, J. 1984: Alpha 1-acid glycoprotein and albumin in human serum bupivacaine binding. Clinical Pharmacology and Therapeutics 35(3): 409-415
Bruguerolle, B.; Bussière, H.; Jadot, G. 1983: Alpha 1-acid glycoprotein and carbamazepine. Revue Neurologique (Paris) 139(11): 679-680
Paxton, J.W.; Briant, R.H. 1984: Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness. British Journal of Clinical Pharmacology 18(5): 806-810
Rodríguez Cuartero, A.; Castillo Higueras, P.L.; Núñez Carril, J.; Mora Lara, R.J. 1983: Alpha 1-acid glycoprotein in diabetes mellitus. Revista Clinica Espanola 170(1-2): 37-40
Philip, A.G.; Hewitt, J.R. 1983: Alpha 1-acid glycoprotein in the neonate with and without infection. Biology of the Neonate 43(3-4): 118-124
Hamazaki, M.; Kurokawa, M.; Hotta, K. 1972: Alpha 1-acid glycoprotein. II. Properties of alpha 1-acid glycoprotein of ascitic and pleural fluids. Seikagaku. Journal of Japanese Biochemical Society 44(6): 255-260
Sawaki, K.; Baum, B.J.; Ambudkar, I.S. 1995: Alpha 1-adrenergic and m3-muscarinic receptor stimulation of phosphatidylinositol 4,5-bisphosphate-specific phospholipase C are independently mediated by G alpha q/11 in rat parotid gland membranes. Archives of Biochemistry and Biophysics 316(1): 535-540
Takuma, T.; Kuyatt, B.L.; Baum, B.J. 1984: Alpha 1-adrenergic inhibition of protein synthesis in rat submandibular cells. American Journal of Physiology 247(3 Part 1): G284-G289
Brown, R.D.; Berger, K.D.; Taylor, P. 1984: Alpha 1-adrenergic receptor activation mobilizes cellular Ca2+ in a muscle cell line. Journal of Biological Chemistry 259(12): 7554-7562
Strang, K.T.; Moss, R.L. 1995: Alpha 1-adrenergic receptor stimulation decreases maximum shortening velocity of skinned single ventricular myocytes from rats. Circulation Research 77(1): 114-120
Venter, J.C.; Horne, P.; Eddy, B.; Greguski, R.; Fraser, C.M. 1984: Alpha 1-adrenergic receptor structure. Molecular Pharmacology 26(2): 196-205
Hayashi, S.; Umemura, S.; Ashino, K.; Hirawa, N.; Toya, Y.; Abe, Y.; Ishii, M. 1995: Alpha 1-adrenergic receptors in cardiac ventricles of Dahl rats. American Journal of Hypertension 8(8): 850-854
Schiffrin, E.L. 1984: Alpha 1-adrenergic receptors in the mesenteric vascular bed of renal and spontaneously hypertensive rats. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 2(3): S431-S432
Proulx-Ferland, L.; Breault, M.; Cote, J. 1982: Alpha 1-adrenergic stimulation of ACTH secretion in vivo in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry 6(4-6): 433-438
Schimmel, R.J.; McCarthy, L.; McMahon, K.K. 1983: Alpha 1-adrenergic stimulation of hamster brown adipocyte respiration. American Journal of Physiology 244(5): C362-C368
Mohell, N.; Wallace, M.; Fain, J.N. 1984: Alpha 1-adrenergic stimulation of phosphatidylinositol turnover and respiration of brown fat cells. Molecular Pharmacology 25(1): 64-69
Duncker, D.J.; Zhang, J.; Crampton, M.J.; Bache, R.J. 1995: Alpha 1-adrenergic tone does not influence the transmural distribution of myocardial blood flow during exercise in dogs with pressure overload left ventricular hypertrophy. Basic Research in Cardiology 90(1): 73-83
Kitakaze, M.; Hori, M.; Morioka, T.; Minamino, T.; Takashima, S.; Okazaki, Y.; Node, K.; Komamura, K.; Iwakura, K.; Itoh, T. 1995: Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 91(8): 2226-2234
Corvera, S.; García-Sáinz, J.A. 1981: Alpha 1-adrenoceptor activation stimulates ureogenesis in rat hepatocytes. European Journal of Pharmacology 72(4): 387-390
Waeber, B.; Nussberger, J.; Brunner, H.R. 1984: Alpha 1-adrenoceptor blockade in renal hypertensive rats with low and high renin levels. American Journal of Physiology 246(4 Part 2): H573-H578
Boschi, D.; Di Stilo, A.; Fruttero, R.; Medana, C.; Sorba, G.; Gasco, A. 1994: Alpha 1-adrenoceptor blocking activity of some ring-open analogues of prazosin. Archiv der Pharmazie 327(10): 661-667
Menkes, D.B.; Gallager, D.W.; Reinhard, J.F.; Aghajanian, G.K. 1983: Alpha 1-adrenoceptor denervation supersensitivity in brain: physiological and receptor binding studies. Brain Research 272(1): 1-12
Lopez-Rodriguez, M.L.; Morcillo, M.J.; Benhamu, B.; Fernandez, E.; Serrano, J.; Orensanz, L. 1995: Alpha 1-adrenoceptor reagents. Synthesis of some 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido and 5,6,11,11b-tetrahydro-1H-imidazo[1',5':1,2]pyrido[3,4-b]indole-1,3(2H) -diones. Chemical and Pharmaceutical Bulletin 43(6): 941-946
Gurdal, H.; Cai, G.; Johnson, M.D. 1995: Alpha 1-adrenoceptor responsiveness in the aging aorta. European Journal of Pharmacology 274(1-3): 117-123
Lepor, H. 1995: Alpha 1-adrenoceptor selectivity: clinical or theoretical benefit?. British Journal of Urology 76(Suppl 1): 57-61
Hanem, S.; Skomedal, T.; Osnes, J.B. 1994: Alpha 1-adrenoceptor stimulation increases 86Rb+ influx in perfused rat heart. Journal of Cardiovascular Pharmacology 24(2): 261-265
Michel, M.C.; Büscher, R.; Kerker, J.; Kraneis, H.; Erdbrügger, W.; Brodde, O.E. 1993: Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor. Naunyn-Schmiedeberg's Archives of Pharmacology 348(4): 385-395
García-Sáinz, J.A.; Romero-Avila, M.T.; Villalobos-Molina, R.; Minneman, K.P. 1995: Alpha 1-adrenoceptor subtype selectivity of tamsulosin: studies using livers from different species. European Journal of Pharmacology 289(1): 1-7
Ivorra, D.; Gascón, S.; Vila, E.; Badia, A. 1993: Alpha 1-adrenoceptor subtypes and inositol phosphates production in heart ventricles of spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology 21(6): 931-936
Abdul Sattar, M.; Johns, E.J. 1994: Alpha 1-adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one-clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats. Journal of Cardiovascular Pharmacology 24(3): 420-428
Fujimoto, S. 1994: Alpha 1-adrenoceptor subtypes mediating contraction of the femoral artery in spontaneously hypertensive rats. Canadian Journal of Physiology and Pharmacology 72(8): 862-869
Gopalakrishnan, S.M.; Chen, C.; Lokhandwala, M.F. 1995: Alpha 1-adrenoceptor subtypes mediating stimulation of Na+,K(+)-ATPase activity in rat renal proximal tubules. European Journal of Pharmacology 288(2): 139-147
Satoh, M.; Kojima, C.; Kokubu, N.; Takayanagi, I. 1994: Alpha 1-adrenoceptor subtypes mediating the regulation and modulation of Ca2+ sensitization in rabbit thoracic aorta. European Journal of Pharmacology 265(3): 133-139
Ouseph, A.K.; Levine, J.D. 1995: Alpha 1-adrenoceptor-mediated sympathetically dependent mechanical hyperalgesia in the rat. European Journal of Pharmacology 273(1-2): 107-112
Timmermans, P.B.; Matthews, W.D.; Demarinis, R.M.; Hieble, J.P.; Mathy, M.J.; Doods, H.N.; Thoolen, M.J.; De Jonge, A.; Wilffert, B.; Van Zwieten, P.A. 1984: Alpha 1-adrenoceptor-mediated vasoconstriction in vivo to enantiomers of SK and F 89748-A. European Journal of Pharmacology 101(1-2): 45-55
Pan, Z.Z.; Grudt, T.J.; Williams, J.T. 1994: Alpha 1-adrenoceptors in rat dorsal raphe neurons: regulation of two potassium conductances. Journal of Physiology 478 Pt 3: 437-447
Cauvin, C.; Loutzenhiser, R.; Hwang, O.; Van Breemen, C. 1982: Alpha 1-adrenoceptors induce Ca influx and intracellular Ca release in isolated rabbit aorta. European Journal of Pharmacology 84(3-4): 233-235
Ruffolo, R.R.; Bondinell, W.; Ku, T.; Naselsky, D.P.; Hieble, J.P. 1995: Alpha 1-adrenoceptors: pharmacological classification and newer therapeutic applications. Proceedings of the Western Pharmacology Society 38: 121-126
Peters, J.R.; Foord, S.M.; Dieguez, C.; Scanlon, M.F.; Hall, R. 1983: Alpha 1-adrenoreceptors on intact rat anterior pituitary cells: correlation with adrenergic stimulation of thyrotropin secretion. Endocrinology 113(1): 133-140
Ohkubo, T.; Yamamura, M.; Kamiguchi, H.; Sahashi, T.; Hayashi, S.; Shiotsuka, Y.; Matsumoto, M.; Kobayashi, K.; Katsunuma, T. 1982: Alpha 1-antichymotrypsin and IgM as DNA-binding protein in serum - a possible diagnosis for malignant ovarian tumors. Tokai Journal of Experimental and Clinical Medicine 7(3): 325-329
Stockley, R.A.; Burnett, D. 1980: Alpha 1-antichymotrypsin in infected and noninfected sputum. American Review of Respiratory Disease 122(1): 81-88
Harigaya, Y.; Shoji, M.; Nakamura, T.; Matsubara, E.; Hosoda, K.; Hirai, S. 1995: Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease. Internal Medicine 34(6): 481-484
Björk, T.; Bjartell, A.; Abrahamsson, P.A.; Hulkko, S.; di Sant'Agnese, A.; Lilja, H. 1994: Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology 43(4): 427-434
Szulczyńska, K.; Zbytniewski, Z.; Kanclerz, A. 1980: Alpha 1-antitrypsin (A-1-AT) level in bronchial asthma. Wiadomosci Lekarskie 33(17): 1359-1364
Welch, S.G.; McGregor, I.A.; Williams, K. 1980: Alpha 1-antitrypsin (pi) phenotypes in a village population from the Gambia, West Africa. Evidence of a new variant occurring at a polymorphic frequency. Human Genetics 53(2): 233-235
Patzelt, D. 1982: Alpha 1-antitrypsin - clinical and forensic aspects. Zeitschrift für Arztliche Fortbildung 76(24): 1008-1011
Massi, G.; Cotumaccia, R.; Auconi, P.; Patriarchi, P.; Mirabella, A.; Rizzo, G. 1982: Alpha 1-antitrypsin PiM subtypes and chronic obstructive pulmonary disease (COPD). Chest 82(4): 513
Wachtfogel, Y.T.; Bischoff, R.; Bauer, R.; Hack, C.E.; Nuijens, J.H.; Kucich, U.; Niewiarowski, S.; Edmunds, L.H.; Colman, R.W. 1994: Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation. Thrombosis and Haemostasis 72(6): 843-847
Kishore, N.; Kishore, B.; Sharma, B.B. 1982: Alpha 1-antitrypsin activity in viral hepatitis. Journal of the Association of Physicians of India 30(2): 73-74
Li Volti, S.; Milone, G.; Di Dio, R. 1983: Alpha 1-antitrypsin and Down's syndrome. La Pediatria 91(2-3): 179-183
Saari, K.M.; Solja, J.; Sirpelä, M.; Frants, R.R.; Eriksson, A.W. 1981: Alpha 1-antitrypsin and acute anterior uveitis. Albrecht Von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology 216(3): 205-207
Adriaans, B.; MacKie, R.M.; Turbitt, M. 1984: Alpha 1-antitrypsin and alpha 1-antichymotrypsin in cutaneous histiocytic lesions and a comparison with lysozyme antibody staining. Journal of the American Academy of Dermatology 10(4): 673-674
Sakamoto, W.; Nishikaze, O. 1980: Alpha 1-antitrypsin and alpha 2-macroglobulin do not inhibit the kinin-releasing activity of kallikreins from human urine and saliva. Biochimica et Biophysica Acta 633(3): 305-309
Yonezawa, S.; Sato, E.; Kakinoki, T.; Ohi, Y. 1982: Alpha 1-antitrypsin and antithrombin IIi in atrophic nephrons of chronic pyelonephritis. Acta Pathologica Japonica 32(2): 193-198
Li Volti, S.; La Rosa, M.; Milone, G.; Musumeci, S. 1984: Alpha 1-antitrypsin and bronchiolitis. Minerva Pediatrica 36(5): 217-220
Cianciara, M.; Pagowska, T. 1984: Alpha 1-antitrypsin and immunoglobulin A, G and M levels in workers occupationally exposed to ceramic dust. Polski Tygodnik Lekarski 39(4): 107-109
Johnson, A.M. 1973: Alpha 1-antitrypsin and infantile respiratory distress. New England Journal of Medicine 288(10): 523
Millán Núñez-Cortés, J. 1984: Alpha 1-antitrypsin and neoplasms. Revista Clinica Espanola 174(3-4): 65-67
Ostler, H.B. 1982: Alpha 1-antitrypsin and ocular sensitivity to cromoglycate. Lancet 2(8310): 1287
Carlson, J.; Eriksson, S. 1980: Alpha 1-antitrypsin and other acute phase reactants in liver disease. Acta Medica Scandinavica 207(1-2): 79-83
Tsuchiya, R.; Noda, T.; Miyamoto, T.; Taniguchi, H. 1980: Alpha 1-antitrypsin and pancreatic neoplasms. Nihon Rinsho. Japanese Journal of Clinical Medicine 38(1): 146-151
Rudyk, B.I.; Baranovskiĭ, P.V. 1982: Alpha 1-antitrypsin content in bronchial asthma patients undergoing immunosuppressive therapy. Vrachebnoe Delo 2: 99-101
Savige, J.A.; Chang, L.; Cook, L.; Burdon, J.; Daskalakis, M.; Doery, J. 1995: Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clinical and Experimental Immunology 100(2): 194-197
Marsico, S.A.; Cantatore, D.; Gennarelli, E. 1981: Alpha 1-antitrypsin deficiency and chronic aspecific respiratory pathology (evaluation of the risk in the heterozygote state). Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 36(3): 119-130
Rabassa, A.A.; Schwartz, M.R.; Ertan, A. 1995: Alpha 1-antitrypsin deficiency and chronic pancreatitis. Digestive Diseases and Sciences 40(9): 1997-2001
Resnick, H.; Lapp, N.; Morgan, W.K. 1970: Alpha 1-antitrypsin deficiency and emphysema. JAMA 211(10): 1701
Le Gall, F.; Deugnier, Y.; Messner, M.; Simon, M.; Bourel, M.; Ferrand, B. 1983: Alpha 1-antitrypsin deficiency and idiopathic hemochromatosis: a fortuitous association. Gastroenterologie Clinique et Biologique 7(12): 1040-1041
Costantini, P.J.; Bradway, W.; Scheuerman, T.; Giudice, J.C. 1983: Alpha 1-antitrypsin deficiency and pulmonary emphysema. Journal of the American Osteopathic Association 82(7): 486-490
Spech, H.J.; Liehr, H. 1982: Alpha 1-antitrypsin deficiency and the liver. Zeitschrift für Gastroenterologie 20(7): 393-404
Crawford, I.P.; Dawson, A.; Stevenson, D.D. 1974: Alpha 1-antitrypsin deficiency associated with PZ and MP phenotypes. Clinical and laboratory correlations. American Journal of Medicine 57(2): 210-216
Lipkin, G.; Galdston, M.; Kueppers, F. 1984: Alpha 1-antitrypsin deficiency genes: contributory defect in a subset of psoriatics?. Journal of the American Academy of Dermatology 11(4 Pt 1): 615-619
Kotulska-Hofmokl, Z.; Chojnowska-Miszewska, W.; Piłacik, B.; Nowak, S. 1982: Alpha 1-antitrypsin deficiency in a newborn infant population and 1-2 year follow-up. Pediatria Polska 57(10): 765-770
Lelong, M.; Lebas, J.; Thelliez, P.; Chauvet, G. 1980: Alpha 1-antitrypsin deficiency in asthma and recurrent respiratory incidents in children. Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 25(7): 358-361
Handa, V.; Oza, R.M.; Ingle, R.R.; Mukherjee, R.A. 1984: Alpha 1-antitrypsin deficiency in cirrhosis of liver. Journal of the Indian Medical Association 82(11): 389-391
Lemercier, J.P.; Ropartz, C.; Langlois, A.; Ourdas, N.; Morier, F.; Desseauve, J. 1969: Alpha 1-antitrypsin deficiency in respiratory pathology (statistical, clinical and genetic study). Journal Francais de Medecine et Chirurgie Thoraciques 23(1): 31-47
Kroner, T. 1973: Alpha 1-antitrypsin deficiency with liver disease and iron overload. Schweizerische Medizinische Wochenschrift 103(34): 1192-1195
Berge, E.; Os, I.; Skjørten, F.; Svalander, C. 1995: Alpha 1-antitrypsin deficiency--not only pulmonary and hepatic involvement. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(7): 823-826
Rodrigo Sáez, L.; Pérez Alvarez, R.; Sánchez Lombraña, J.L.; Martínez Alonso, C.; González González, M.; Ocio Achaerandio, G. 1982: Alpha 1-antitrypsin deficiency: description of a personal roster of 24 cases. Revista Espanola de Las Enfermedades del Aparato Digestivo 62(3): 209-216
Rorive, C.; Schoos, R.; Dodinval-Versie, J.; Husquinet, H.; Lambotte, C.; Dodinval, P. 1982: Alpha 1-antitrypsin deficiency: evaluation and perspectives. Apropos of 1000 instances of assay and genetic typing. Revue Medicale de Liege 37(17): 591-598
Milicua, J.M.; Faro, M.V.; Moreno, A.; García Sagredo, J.M.; Domínguez, A.; Capela, I.; Ocio, G. 1981: Alpha 1-antitrypsin deficiency: report of a new familial case. Revista Espanola de Las Enfermedades del Aparato Digestivo 59(4): 497-502
Eriksson, S.; Laurell, C.B.; Eriksson, S. 1984: Alpha 1-antitrypsin deficiency: some personal experiences. Schweizerische Medizinische Wochenschrift 114(25): 893-894
Gishen, P.; Saunders, A.J.; Tobin, M.J.; Hutchison, D.C. 1982: Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association. Clinical Radiology 33(4): 371-377
Cordero Torres, R.; Saenz de Santamaría, F.J.; Lozano Gutiérrez, F.; Soria Monge, A.; Pérez Miranda, M. 1983: Alpha 1-antitrypsin deficit associated with Paget's disease. Revista Clinica Espanola 171(6): 437-438
Koch, F.; Schwick, H.G.; Störiko, K. 1965: Alpha 1-antitrypsin determinations in the serum of patients with mucoviscoidosis. Klinische Wochenschrift 43(20): 1120
Petrović, J.; Trajković, D.; Radojcić, M.; Matić, G.; Milovanov, N.; Todorović, O. 1982: Alpha 1-antitrypsin genetic phenotypes in a group of children suffering from pulmonary diseases. Respiration; International Review of Thoracic Diseases 43(2): 127-131
Gilutz, H.; Siegel, Y.; Paran, E.; Cristal, N.; Quastel, M.R. 1983: Alpha 1-antitrypsin in acute myocardial infarction. British Heart Journal 49(1): 26-29
Busch, R.; Wilms, K. 1974: Alpha 1-antitrypsin in burns and scalds. Kinderarztliche Praxis 42(8): 352-356
Schneeweiss, B.; Kaden, K.; Patzelt, D. 1981: Alpha 1-antitrypsin in children with bronchial asthma. Padiatrie und Grenzgebiete 20(4): 255-259
Kapellerová, A.; Sulko, M.; Hupka, V. 1984: Alpha 1-antitrypsin in nasopharyngeal secretions in acute respiratory diseases. Ceskoslovenska Pediatrie 39(9): 501-502
Braxel, C.; Versieck, J.; Lemey, G.; Vanballenberghe, L.; Barbier, F. 1982: Alpha 1-antitrypsin in pancreatitis. Digestion 23(2): 93-96
Fargion, S.; Klasen, E.C.; Lalatta, F.; Sangalli, G.; Tommasini, M.; Fiorelli, G. 1981: Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis. Clinical Genetics 19(2): 134-139
Karitzky, D. 1974: Alpha 1-antitrypsin in septic infections during infancy. Zeitschrift für Kinderheilkunde 117(4): 281-289
Chan, S.K. 1973: Alpha 1-antitrypsin in sera of inbred mice. Archives of Environmental Health 27(4): 272
Swedlund, H.A.; Hunder, G.G.; Gleich, G.J. 1974: Alpha 1-antitrypsin in serum and synovial fluid in rheumatoid arthritis. Annals of the Rheumatic Diseases 33(2): 162-164
Romeo, M.A.; Milone, G.; Emma, F.; Li Volti, S.; Di Dio, R.; Musumeci, S. 1983: Alpha 1-antitrypsin in thalassemia major. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 5(5): 351-353
Jendryczko, A.; Kucharz, E. 1983: Alpha 1-antitrypsin in the blood serum of patients with systemic lupus erythematosus. Polski Tygodnik Lekarski 38(44): 1361-1362
De la Fuente Perucho, A.; Millán, J.; Paya, J.M.; de la Fuente Alarcón, A. 1983: Alpha 1-antitrypsin in the gastric and duodenal contents in ulcer patients. I) Levels and correlations with the pH. Revista Espanola de Las Enfermedades del Aparato Digestivo 63(6): 513-517
Fierer, J.A.; Mandl, I.; Evans, H.E. 1974: Alpha 1-antitrypsin in the lungs of newborn infants with respiratory distress syndrome. Journal of Pediatrics 85(5): 698-701
Rao, C.N.; Ladin, D.A.; Liu, Y.Y.; Chilukuri, K.; Hou, Z.Z.; Woodley, D.T. 1995: Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. Journal of Investigative Dermatology 105(4): 572-578
Gola, A.; Gałazka, Z.; Tychowski, K. 1980: Alpha 1-antitrypsin level and the state of the respiratory tract in arc welders. Medycyna Pracy 31(1): 41-44
Tuszkiewicz-Misztal, E. 1981: Alpha 1-antitrypsin level in children with juvenile diabetes mellitus. Pediatria Polska 56(2): 139-141
Zazgornik, J.; Kopsa, H.; Schmidt, P.; Pils, P.; Balcke, P.; Hysek, H.; Deutsch, E. 1980: Alpha 1-antitrypsin level in serum of dialyzed and renal transplant patients. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 18(4): 241-244
Vegnente, A.; Toscano, P.; Nuzzo, V.; Ambrogio, G.; Sollazzo, R. 1984: Alpha 1-antitrypsin levels and phenotype in celiac disease in the child and in the adult in Campania. Minerva Pediatrica 36(17): 831-834
Webb, D.B.; Fifield, R.A. 1984: Alpha 1-antitrypsin levels in paraquat poisoning. Human Toxicology 3(4): 315-317
Calderón Rodríguez, J.; Docio, S.; Riestra, J.L.; Merino, J.; García Fuentes, M.; Rodríguez Valverde, V. 1983: Alpha 1-antitrypsin phenotype and rheumatoid arthritis. Medicina Clinica 81(5): 191-193
Hug, G.; Chuck, G.; Bowles, B. 1982: Alpha 1-antitrypsin phenotype: transient cathodal shift in serum of infant girl with urinary cytomegalovirus and fatty liver. Pediatric Research 16(3): 192-198
Massi, G.; Fabiano, A.; Ragusa, D.; Auconi, P.; Biagini, R.; Farinato, M.A.; Bandelloni, R. 1980: Alpha 1-antitrypsin phenotypes and pi m subtypes in Italy. Bulletin Europeen de Physiopathologie Respiratoire 16 Suppl: 301-306
Singh, R.; Horne, S.L.; Gerrard, J.W.; DeCoteau, W.E. 1983: Alpha 1-antitrypsin phenotypes in Canadian Metis. Human Heredity 33(3): 181-183
Beckman, G.; Beckman, L.; Nordenson, I. 1980: Alpha 1-antitrypsin phenotypes in Northern Sweden. Human Heredity 30(3): 129-135
Olusi, S.O.; Ladipo, G.O.; Ojutiku, O.O. 1982: Alpha 1-antitrypsin phenotypes in a Nigerian population. African Journal of Medicine and Medical Sciences 10(3-4): 113-117
Lhotta, K.; Vogel, W.; Meisl, T.; Buxbaum, M.; Neyer, U.; Sandholzer, C.; König, P. 1994: Alpha 1-antitrypsin phenotypes in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis. Clinical Science 87(6): 693-695
Vandeville, D.; Martin, J.P.; Ropartz, C. 1974: Alpha 1-antitrypsin polymorphism of a Bantu population: description of a new allele PiL. Humangenetik 21(1): 33-38
Biemond, I.; Selby, W.S.; Jewell, D.P.; Klasen, E.C. 1984: Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitis. Digestion 29(2): 124-128
Lellouch, J.; Claude, J.R. 1980: Alpha 1-antitrypsin serum concentration and respiratory symptoms in 1294 healthy men. Bulletin Europeen de Physiopathologie Respiratoire 16 Suppl: 307-314
Karbach, U.; Ewe, K.; Bodenstein, H. 1983: Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 24(8): 718-723
Tahara, E.; Ito, H.; Taniyama, K.; Yokozaki, H.; Hata, J. 1984: Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study. Human Pathology 15(10): 957-964
van Sande, M.; Van Camp, K. 1983: Alpha 1-antitrypsin, alpha 2-macroglobulin and complement C4 in human benign prostatic hyperplasia. Urological Research 11(6): 275-277
Carrell, R.W. 1984: Alpha 1-antitrypsin, emphysema and smoking. New Zealand Medical Journal 97(756): 327-328
Casslén, B.; Ohlsson, K. 1981: Alpha 1-antitrypsin--complexation and inactivation in the uterine fluid of IUD-users. Acta Obstetricia et Gynecologica Scandinavica 60(2): 103-107
Bata, J.; Cordier, G. 1982: Alpha 1-antitrypsin/lymphocyte interactions: cytofluorometry study. Annales d'Immunologie 133d (3): 263-268
Brown, W.T. 1982: Alpha 1-antitrypsin: apparent molecular weight heterogeneity shown by two-dimensional electrophoresis. American Journal of Human Genetics 34(2): 195-208
Lohrisch, I.; Scherbaum, I.; Gruhn, R.; Ambrosius, H.; Haustein, U.F.; Herrmann, K. 1981: Alpha 1-antitrypsin: production and binding of in vitro stimulated peripheral blood lymphocytes. Acta Biologica et Medica Germanica 40(12): 1767-1773
Feldmann, G. 1984: Alpha 1-antitrypsin; new perspectives. Gastroenterologie Clinique et Biologique 8(8-9): 667-675
Giorda, C.; Appendino, M.; Mason, M.G.; Imperiale, E.; Pagano, G. 1995: Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients. Metabolism, Clinical and Experimental 44(5): 673-676
Andersen, J.T. 1995: Alpha 1-blockers vs 5 alpha-reductase inhibitors in benign prostatic hyperplasia. a comparative review. Drugs and Aging 6(5): 388-396
Wrede, A.; Borucka-Mankiewicz, M.; Jezuita, J.; Wiśniewski, L. 1984: Alpha 1-fetoprotein and acetylcholinesterase as markers of defects of the central nervous system in fetuses. Polski Tygodnik Lekarski 39(40-41): 1323-1326
Vuopio, P. 1970: Alpha 1-fetoprotein and cancer. Duodecim; Laaketieteellinen Aikakauskirja 86(20): 1155-1157
Hattori, S.; Mukijima, T.; Hasagawa, H.; Kitaoka, K.; Okazaki, N. 1970: Alpha 1-fetoprotein and cancer-specific protein. Nihon Rinsho. Japanese Journal of Clinical Medicine 28(8): 2130-2133
Norgaard-Pedersen, B.; Klebe, J.G. 1974: Alpha 1-fetoprotein and carbonic anhydrase B and C concentration in cord blood from newborn infants of diabetic mothers. Acta Endocrinologica. Supplementum 182: 81-86
Zizkovský, V.; Kordac, V.; Masopust, J.; Obrovská, D.; Stĕpán, J. 1974: Alpha 1-fetoprotein and carcinoembryonic antigen in a patient with carcinoid of the stomach. Gan 65(3): 193-199
Horn, F.; Hedinger, C.; Grob, P.J. 1980: Alpha 1-fetoprotein and testicular neoplasms. Schweizerische Medizinische Wochenschrift 110(17): 642-647
Innotti, G.; Rullo, F.; Papa, R.; Catalano, D. 1980: Alpha 1-fetoprotein as an indicator of fetal maturity, well-being or distress. Archivio di Ostetricia E Ginecologia 85(5): 375-386
Teres, J.; Bertran, A.; Mas, A.; Gras, J. 1970: Alpha 1-fetoprotein in Spain. Lancet 2(7670): 465
Buffe, D.; Rimbaut, C. 1973: Alpha 1-fetoprotein in liver diseases and metabolic disorders in children. Biomedicine / 19(4): 172-176
Seppälä, M. 1973: Alpha 1-fetoprotein in obstetrics. Duodecim; Laaketieteellinen Aikakauskirja 89(20): 1353-1354
Schäfer, H.; Althoff, H. 1982: Alpha 1-fetoprotein in the post mortem diagnosis in sudden infant death. Beitrage Zur Gerichtlichen Medizin 40: 175-181
Lambert, I.; Jaworska, J.; Mazurczak, T.; Wolańska, W.; Mazur, J.; Mikiel-Kostyra, K.; Klawe, H. 1983: Alpha 1-fetoprotein levels of the amniotic fluid in relation to the presence of blood in amniotic fluid. Ginekologia Polska 54(8-9): 531-535
Wollina, U. 1984: Alpha 1-fetoprotein--relation to impaired macrophage function in systemic lupus erythematosus?. Dermatologische Monatschrift 170(11): 703-704
Lober, R.; Lober, M.; Krantz, S. 1983: Alpha 1-globulin levels in patients with cancer of the genital tract. Zentralblatt für Gynakologie 105(5): 294-296
Akerström, B.; Lögdberg, L. 1984: Alpha 1-microglobulin glycopeptides inhibit antigen-specific stimulation of human peripheral blood leucocytes. Scandinavian Journal of Immunology 20(6): 559-563
Nogawa, K.; Kido, T.; Yamada, Y.; Tsuritani, I.; Honda, R.; Ishizaki, M.; Terahata, K. 1984: Alpha 1-microglobulin in urine as an indicator of renal tubular damage caused by environmental cadmium exposure. Toxicology Letters 22(1): 63-68
Nock, B.; Feder, H.H. 1984: Alpha 1-noradrenergic regulation of hypothalamic progestin receptors and guinea pig lordosis behavior. Brain Research 310(1): 77-85
Hansen, G.; Schuster, A.; Zubrod, C.; Wahn, V. 1995: Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum. Respiration; International Review of Thoracic Diseases 62(3): 117-124
Miszczuk-Jamska, B.; Guy, O.; Figarella, C. 1983: Alpha 1-proteinase inhibitor in pure human pancreatic juice. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 364(5): 509-513
Miszczuk-Jamska, B.; Guy, O.; Figarella, C. 1983: Alpha 1-proteinase inhibitor in pure human pancreatic juice. Characterization of a complexed form in patients with chronic calcifying pancreatitis and its significance. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 364(11): 1597-1601
Janoff, A.; Dearing, R. 1982: Alpha 1-proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase. American Review of Respiratory Disease 126(4): 691-694
Timmermans, P.B.; Mathy, M.J.; Wilffert, B.; Kalkman, H.O.; Smit, G.; Dijkstra, D.; Horn, A.S.; Van Zwieten, P.A. 1984: Alpha 1/alpha 2-adrenoceptor agonist selectivity of mono- and dihydroxy-2-N,N-DI-n-propylaminotetralins. European Journal of Pharmacology 97(1-2): 55-65
Satoh, M.; Kokubu, N.; Matsuo, K.; Takayanagi, I. 1995: Alpha 1A-adrenoceptor subtype effectively increases Ca(2+)-sensitivity for contraction in rabbit thoracic aorta. General Pharmacology 26(2): 357-362
Chess-Williams, R.; Aston, N.; Couldwell, C. 1994: Alpha 1A-adrenoceptor subtype mediates contraction of the rat urethra. Journal of Autonomic Pharmacology 14(6): 375-381
Williamson, A.P.; Seifen, E.; Lindemann, J.P.; Kennedy, R.H. 1994: Alpha 1a-adrenergic receptor mediated positive chronotropic effect in right atria isolated from rats. Canadian Journal of Physiology and Pharmacology 72(12): 1574-1579
Mbuyi-Muamba, J.M.; Dequeker, J.; Stevens, E. 1982: Alpha 2 HS-glycoprotein in rheumatoid arthritis. its plasma concentration and possible biological role. Revue du Rhumatisme et des Maladies Osteo-Articulaires 49(7): 515-518
Flordellis, C.S.; Berguerand, M.; Gouache, P.; Barbu, V.; Gavras, H.; Handy, D.E.; Béréziat, G.; Masliah, J. 1995: Alpha 2 adrenergic receptor subtypes expressed in Chinese hamster ovary cells activate differentially mitogen-activated protein kinase by a p21ras independent pathway. Journal of Biological Chemistry 270(8): 3491-3494
Wikberg, J.E.; Lefkowitz, R.J. 1982: Alpha 2 adrenergic receptors are located prejunctionally in the Auerbach's plexus of the guinea pig small intestine: direct demonstration by radioligand binding. Life Sciences 31(25): 2899-2905
Evans, R.G.; Haynes, J.M. 1995: Alpha 2 adrenoceptor- and imidazoline-preferring binding sites in the dog kidney. Annals of the new York Academy of Sciences 763: 357-360
Parle, M.; Kulkarni, S.K. 1984: Alpha 2 adrenoceptor-mediated contraction of frog rectus abdominis muscle. Archives Internationales de Pharmacodynamie et de Therapie 271(1): 122-126
Kiowski, W.; Hulthén, U.L.; Ritz, R.; Bühler, F.R. 1983: Alpha 2 adrenoceptor-mediated vasoconstriction of arteries. Clinical Pharmacology and Therapeutics 34(5): 565-569
Nurse, B.; Russell, V.A.; Taljaard, J.J. 1984: Alpha 2 and beta-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: implications for research into depression. Neurochemical Research 9(9): 1231-1238
Müller, H.; Kluthe, R. 1971: Alpha 2 globulins in diabetes mellitus. Medizinische Klinik 66(14): 522-526
Pagano, M.; Engler, R. 1984: Alpha 2 high molecular mass cysteine proteinase inhibitor: HMr alpha 2-CPI. An inhibitor of human liver cathepsin H as probed by kinetic study. Febs Letters 166(1): 62-66
Majuri, M.L.; Pinola, M.; Niemelä, R.; Tiisala, S.; Natunen, J.; Renkonen, O.; Renkonen, R. 1994: Alpha 2,3-sialyl and alpha 1,3-fucosyltransferase-dependent synthesis of sialyl Lewis x, an essential oligosaccharide present on L-selectin counterreceptors, in cultured endothelial cells. European Journal of Immunology 24(12): 3205-3210
Matsuda, M.; Wakabayashi, K.; Aoki, N.; Morioka, Y. 1980: Alpha 2-Plasmin inhibitor is among acute phase reactants. Thrombosis Research 17(3-4): 527-532
Yamazaki, S.; Katada, T.; Ui, M. 1982: Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets. Molecular Pharmacology 21(3): 648-653
Sundin, U.; Fain, J.N. 1983: Alpha 2-adrenergic inhibition of lipolysis and respiration in rat brown adipocytes. Biochemical Pharmacology 32(20): 3117-3120
Ajikobi, D.O.; Cupples, W.A. 1994: Alpha 2-adrenergic mediation of the effects of angiotensin Ii on rat renal artery in vitro. Canadian Journal of Physiology and Pharmacology 72(9): 1019-1024
Lockette, W.; Ghosh, S.; Farrow, S.; MacKenzie, S.; Baker, S.; Miles, P.; Schork, A.; Cadaret, L. 1995: Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. American Journal of Hypertension 8(4 Part 1): 390-394
Brambilla, F.; Perna, G.; Garberi, A.; Nobile, P.; Bellodi, L. 1995: Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder. Psychoneuroendocrinology 20(1): 1-9
Brambilla, F.; Bellodi, L.; Arancio, C.; Nobile, P.; Perna, G. 1995: Alpha 2-adrenergic receptor sensitivity in panic disorder: II. Cortisol response to clonidine stimulation in panic disorder. Psychoneuroendocrinology 20(1): 11-19
Kahn, D.J.; Mitrius, J.C.; U'Prichard, D.C. 1982: Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase. Molecular Pharmacology 21(1): 17-26
Iuvone, P.M.; Rauch, A.L. 1983: Alpha 2-adrenergic receptors influence tyrosine hydroxylase activity in retinal dopamine neurons. Life Sciences 33(24): 2455-2463
Bruynzeel, P.L.; Hamelink, M.L.; Kok, P.T.; van der Vet, A.P.; Kreukniet, J. 1984: Alpha 2-adrenergic receptors on intact human platelets of normal individuals and chronic obstructive lung disease patients. European Journal of Respiratory Diseases. Suppl 135: 139-142
Saha, S.; Hellman, B. 1995: Alpha 2-adrenergic stimulation counteracts glucose-induced rise of sodium in pancreatic islets exposed to ouabain. Acta Diabetologica 32(2): 82-85
Mizobe, T.; Maze, M. 1995: Alpha 2-adrenoceptor agonists and anesthesia. International Anesthesiology Clinics 33(1): 81-102
Shepperson, N.B. 1984: Alpha 2-adrenoceptor agonists potentiate responses mediated by alpha 1-adrenoceptors in the cat nictitating membrane. British Journal of Pharmacology 83(2): 463-469
Lattimer, N.; McAdams, R.P.; Rhodes, K.F.; Sharma, S.; Turner, S.J.; Waterfall, J.F. 1984: Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology 327(4): 312-318
Haller, J.; Barna, I.; Kovács, J.L. 1994: Alpha 2-adrenoceptor blockade, pituitary-adrenal hormones, and agonistic interactions in rats. Psychopharmacology 115(4): 478-484
De Villiers, A.S.; Russell, V.A.; Sagvolden, T.; Searson, A.; Jaffer, A.; Taljaard, J.J. 1995: Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochemical Research 20(4): 427-433
Wright, I.K.; Kendall, D.A.; Wilson, V.G. 1995: Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins. Naunyn-Schmiedeberg's Archives of Pharmacology 352(2): 113-120
Göthert, M.; Molderings, G.J.; Fink, K.; Schlicker, E. 1995: Alpha 2-adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurons. Annals of the new York Academy of Sciences 763: 405-419
Boeckxstaens, G.E.; De Man, J.G.; Pelckmans, P.A.; Herman, A.G.; Van Maercke, Y.M. 1993: Alpha 2-adrenoceptor-mediated modulation of the nitrergic innervation of the canine isolated ileocolonic junction. British Journal of Pharmacology 109(4): 1079-1084
Jinsi, A.; Deth, R.C. 1995: Alpha 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase. European Journal of Pharmacology 277(1): 29-34
Smyth, D.D.; Umemura, S.; Pettinger, W.A. 1984: Alpha 2-adrenoceptors and sodium reabsorption in the isolated perfused rat kidney. American Journal of Physiology 247(4 Part 2): F680-F685
Spraggs, C.F.; Bunce, K.T. 1983: Alpha 2-adrenoceptors and the delay of castor oil-induced diarrhoea by clonidine in rats. Journal of Pharmacy and Pharmacology 35(5): 321-322
Tozawa, M.; Takishita, S.; Sunagawa, O.; Muratani, H.; Imai, C.; Kawazoe, N.; Fukiyama, K. 1995: Alpha 2-adrenoceptors in brain and kidney during development of hypertension in Dahl-Iwai salt-sensitive rats. Clinical and Experimental Hypertension 17(6): 955-976
Titinchi, S.; Clark, B. 1984: Alpha 2-adrenoceptors in human lymphocytes: direct characterisation by [3H]yohimbine binding. Biochemical and Biophysical Research Communications 121(1): 1-7
Minuth, M.; Jakobs, K.H. 1983: Alpha 2-adrenoceptors in platelets of spontaneously hypertensive rats. Naunyn-Schmiedeberg's Archives of Pharmacology 322(2): 98-103
Nakaki, T.; Nakadate, T.; Yamamoto, S.; Kato, R. 1982: Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation. Naunyn-Schmiedeberg's Archives of Pharmacology 318(3): 181-184
Nakaki, T.; Nakadate, T.; Kato, R. 1980: Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets. Naunyn-Schmiedeberg's Archives of Pharmacology 313(2): 151-153
Codd, E.E.; Press, J.B.; Raffa, R.B. 1995: Alpha 2-adrenoceptors vs. imidazoline receptors: implications for alpha 2-mediated analgesia and other non-cardiovascular therapeutic uses. Life Sciences 56(2): 63-74
Thompson, D.A.; Pénicaud, L.; Welle, S.L. 1984: Alpha 2-adrenoreceptor stimulation inhibits thermogenesis and food intake during glucoprivation in humans. American Journal of Physiology 247(3 Part 2): R560-R566
García-Sevilla, J.A.; Hollingsworth, P.J.; Smnith, C.B. 1981: Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs. European Journal of Pharmacology 74(4): 329-341
Cohen, M.L.; Shaar, C.J.; Colbert, W.E. 1984: Alpha 2-agonist activity of the dopamine DA2-agonist LY171555. Journal of Cardiovascular Pharmacology 6(6): 1245-1248
Weissbach, G.; Domula, M.; Rieske, K. 1982: Alpha 2-antiplasmin in childhood. Folia Haematologica 109(1): 161-170
Sánchez Martín, S.; García Díez, L.C.; García Marcos, M.A.; Miralles García, J.M. 1983: Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy. Revista Clinica Espanola 169(3): 189-190
Albertinale, G.; Casale, G. 1982: Alpha 2-antiplasmin in stroke. Haematologica 67(6): 946
Weitz, J.I.; Leslie, B.; Hirsh, J.; Klement, P. 1993: Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis. Journal of Clinical Investigation 91(4): 1343-1350
Muñoz-Navas, M.; Amiguet, J.A.; Conchillo, F.; Liso, P. 1984: Alpha 2-globulins in the biologic diagnosis of gastric carcinoma. Behavior of ceruloplasmin. Revista Espanola de Las Enfermedades del Aparato Digestivo 66(1): 39-42
Rotkina, I.E.; Mitrofanov, N.A.; Zorina, R.M. 1984: Alpha 2-glucoprotein content in normal menstrual cycle and dysfunctional uterine hemorrhages. Akusherstvo i Ginekologiia 10: 74-75
Warecka, K. 1982: Alpha 2-glycoprotein. Scandinavian Journal of Immunology. Suppl 9: 279-297
Morabito, F.; Callea, V.; Oliva, B.; Stelitano, C.; Vincelli, I.; Molica, S.; Alberti, A.; Brugiatelli, M.; Nobile, F. 1993: Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation. Leukemia 7(3): 366-371
Hoffman, M.; Feldman, S.R.; Pizzo, S.V. 1983: Alpha 2-macroglobulin 'fast' forms inhibit superoxide production by activated macrophages. Biochimica et Biophysica Acta 760(3): 421-423
Petersen, C.M. 1993: Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology. Danish Medical Bulletin 40(4): 409-446
De Strooper, B.; Van Leuven, F. 1993: Alpha 2-macroglobulin and subacute-phase responses in Alzheimer's disease. Immunology Today 14(3): 143-144
Gonias, S.L.; LaMarre, J.; Crookston, K.P.; Webb, D.J.; Wolf, B.B.; Lopes, M.B.; Moses, H.L.; Hayes, M.A. 1994: Alpha 2-macroglobulin and the alpha 2-macroglobulin receptor/LRP. a growth regulatory axis. Annals of the new York Academy of Sciences 737: 273-290
Savona, C.; Negoescu, A.; Labat-Moleur, F.; Keramidas, M.; Shi, D.L.; Chambaz, E.M.; Feige, J.J. 1994: Alpha 2-macroglobulin and the control of adrenocortical steroidogenic function. Annals of the new York Academy of Sciences 737: 399-408
Beremeenko, K.N.; Kizim, A.I.; Kolesnik, L.A. 1984: Alpha 2-macroglobulin and the mechanism of its interaction with proteinases. Vestnik Akademii Meditsinskikh Nauk SSSR 8: 60-64
Gettins, P.G.; Hahn, K.H.; Crews, B.C. 1995: Alpha 2-macroglobulin bait region variants. a role for the bait region in tetramer formation. Journal of Biological Chemistry 270(23): 14160-14167
Hanover, J.A.; Rudick, J.E.; Willingham, M.C.; Pastan, I. 1983: Alpha 2-macroglobulin binding to cultured fibroblasts: identification by affinity chromatography of high-affinity binding sites. Archives of Biochemistry and Biophysics 227(2): 570-579
Niemuller, C.A.; Randall, K.J.; Webb, D.J.; Gonias, S.L.; LaMarre, J. 1995: Alpha 2-macroglobulin conformation determines binding affinity for activin a and plasma clearance of activin A/alpha 2-macroglobulin complex. Endocrinology 136(12): 5343-5349
Dubin, A.; Potempa, J.; Silberring, J. 1984: Alpha 2-macroglobulin from horse plasma. Purification, properties and interaction with certain serine proteinases. Biochemistry International 8(4): 589-596
Lysiak, J.J.; Hussaini, I.M.; Webb, D.J.; Glass, W.F.; Allietta, M.; Gonias, S.L. 1995: Alpha 2-macroglobulin functions as a cytokine carrier to induce nitric oxide synthesis and cause nitric oxide-dependent cytotoxicity in the RAW 264.7 macrophage cell line. Journal of Biological Chemistry 270(37): 21919-21927
Borth, W. 1984: Alpha 2-macroglobulin in connective tissue matrix metabolism. Collagen and Related Research 4(1): 83-94
Araújo-Jorge, T.C.; Luz, M.R.; Coutinho, C.M.; Medrano, N.; Soeiro, M.N.; Meirelles, M.N.; Isaac, L.; Van Leuven, F. 1994: Alpha 2-macroglobulin in experimental and human Chagas' disease. Annals of the new York Academy of Sciences 737: 453-455
Brown, D.J.; Khan, J.A.; Copeland, G.; Jewell, D.P. 1980: Alpha 2-macroglobulin in patients with inflammatory bowel disease. Journal of Clinical and Laboratory Immunology 4(1): 53-57